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Summary 
 
   This evaluation of the non-commercial (Q)SARs for mutagenicity and carcinogenicity consisted 
of a preliminary survey (Phase I), and then of a more detailed analysis of short listed models (Phase 
II). In Phase I, the models were collected from the literature, and then assessed according to the 
OECD principles –based on the information provided by the authors-. Phase I provided the support 
for short listing a number of promising models, that were analyzed more in depth in Phase II. In 
Phase II, the information provided by the authors was completed and complemented with a series of 
analyses aimed at generating an overall profile of each of the short listed models.  
The models can be divided into two families based on their target: a) congeneric;  and b) non-
congeneric sets of chemicals.  
The QSARs for congeneric chemicals include most of the chemical classes top ranking in the EU 
High Production Volume list, with the notable exception of the halogenated aliphatics. They almost 
exclusively aim at modeling Salmonella mutagenicity and rodent carcinogenicity, which are crucial 
toxicological endpoints in the regulatory context. The lack of models for in vivo genotoxicity should 
be remarked. Overall the short listed models can be interpreted mechanistically, and agree with, 
and/or support the available scientific knowledge, and most of the models have good statistics. 
Based on external prediction tests, the QSARs for the potency of congeneric chemicals are 30 to 70 
% correct, whereas the models for discriminating between active and inactive chemicals have 
considerably higher accuracy (63 to 100 %), thus indicating that predicting intervals is more reliable 
than predicting individual data points. The internal validation procedures (e.g., cross-validation, 
etc...) did not seem to be a reliable measure of external predictivity.   
Among the non-local, or global approaches for non-congeneric data sets, four models based on the 
use of Structural Alerts (SA) were short listed and investigated in more depth. The four sets did not 
differ to a large extent in their performance. In the “general” databases of chemicals the SAs appear 
to agree around 65% with rodent carcinogenicity data,  and 75% with Salmonella mutagenicity data. 
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The SAs based models do not seem to work equally efficiently in the discrimination between active 
and inactive chemicals within individual chemical classes. Thus, their main role is that of 
preliminary, or large-scale screenings. A priority for future research on the SAs is their expansion to 
include alerts for nongenotoxic carcinogens.  
   A general indication of this study, valid for both congeneric and noncongeneric models, is that 
there is uncertainty associated with (Q)SARs; the level of uncertainty has to be considered when 
using (Q)SAR in a regulatory context. However, (Q)SARs are not meant to be black-box machines 
for predictions, but have a much larger scope including organization and rationalization of data, 
contribution to highlight mechanisms of action, complementation of other data from different 
sources (e.g., experiments). Using only non-testing methods, the larger the evidence from QSARs 
(several different models, if available) and other approaches (e.g. chemical categories, read across) 
the higher the confidence in the prediction. 
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1 Introduction 
 
    The work performed for this project by the Istituto Superiore di Sanita’ is part of a wide range of 
initiatives coordinated by the European Chemicals Bureau – Joint Research Centre for the technical 
preparations necessary to implement REACH in EU. ECB coordinates the JRC Action on 
Computational Toxicology, which aims to promote the availability of valid (Q)SARs and related 
estimation methods for possible regulatory use. This case study on the validation of non-
commercial (Q)SAR models for mutagencity and carcinogenicity follows previous case studies 
coordinated by ECB on selected endpoints, such as acute fish toxicity, skin sensitization, skin 
penetration, binding to the estrogen and androgen receptors. This project considers only the non-
commercial (Q)SAR models for mutagenicity and carcinogenicity. For this reason, very popular 
models obtained through the application of e.g., MultiCase, Topkat, DEREK, ADAPT and PASS 
software systems were excluded from this study.  
   According to the lines indicated in the contract, the first step of the work was a survey of the 
literature, and the collection of the existing (Q)SAR models. This was followed by an evaluation 
organized in two phases. In Phase 1, the models were evaluated based on the information reported 
by the authors. A scoring system inspired to the OECD principles was designed by us to provide 
support in this task. For the QSAR models focusing on individual chemical classes, additional 
criteria were the industrial / environmental importance of the chemical class. The scores from Phase 
1 pointed to a short list of most promising models, to be considered in depth in Phase 2. Among 
others, the transparency and availability of information on the models has played a crucial role in 
Phase 1. In Phase 2, for each of the short-listed models extensive validation work was carried out, 
consisting of: Level A) verification of  the algorithm and relative statistics, cross-validation, 
exploration of the applicability domain; Level B) whenever feasible, validation using an 
independent test set (assessment of predictivity).  
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    This work generated assessments of the short listed models, as well as overall final 
considerations.  
   To present the results of Phase I, and to put them in a wider perspective, a Workshop on (Q)SAR 
Modeling of Mutagenicity and Carcinogenicity was co-organised by the Istituto Superiore di Sanita 
and ECB (Rome, 22 - 23 June 2006; Romualdo Benigni, Chairman), with contributions provided by 
a number of researchers from academia, regulatory authorities and private companies. The 
presentations at the Workshop were summarized in a report paper, recently submitted for 
publication. The paper provides a review and state of the art in the modeling of mutagenicity and 
carcinogenicity as well as views and opinions of the individual authors on more general issues such 
as validity of (Q)SAR models and reliability of their predictions.  
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Collection, filtering and scoring of (Q)SAR models 
 
   A total of 78 non-commercial (Q)SAR models were collected from the literature (see list in 
Appendix 1). The list categorizes the models into the classes of: 1) models for congeneric sets of 
chemicals. These models were mainly obtained through the application of the Hansch approach, or 
of Hansch-like discriminant analysis; 2) non-local, or general models for noncongeneric sets of 
chemicals. Group 1 is further subdivided according to the chemical class and the toxicological end-
point. 
    
   The models in Appendix 1 vary to a large extent in terms of scientific value, breadth and scope. 
Preliminary to short-listing the models relevant to the EU regulatory needs, first a “quick” filter was 
applied, followed by a more systematic scoring of the “surviving” models. It should be emphasized 
that all the listed models contribute with interesting pieces of information. Even if not relevant 
immediately to the regulatory scopes, they may be the basis for further future developments; thus, it 
is important to keep track of them.  
   The “quick” filter eliminated the following (classes of) models (see Appendix 1): 
a) non regulatory end-points, outside REACH scopes (e.g., models for metabolism, for 
pharmaceuticals and food, non official methods): 15, 27, 43, 44, 45, 51, 52, 53, 54, 67, 78; 
b) methodological studies e.g., focusing on mechanism representation, or parameters validation: 2, 
3, 16, 22, 37, 38, 39, 43 ; 
c) models replaced by subsequent, more refined models: 1, 17, 18, 19, 20, 29, 30, 31, 51, 66, 75; 
d) models based on very small data sets ( n < 15):  40, 41, 55, 57, 58, 59. 
   In total, 36 papers were excluded from a more formal evaluation. 
    
   The models that survived the above step were classified and given scores, by and large based on 
the OECD principles. The scoring system was elaborated by us specifically for this work: It is 
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provided in Scheme 1. The scoring system is aimed at providing characterization profiles of the 
individual models, as a basis for the subsequent short listing. For each heading, the best score is 1; 
higher figures correspond to lower quality ratings. In this way, the best profile is that of models 
with the lowest overall numerical figures.  
   It should be emphasized that the score system adopted in this phase characterizes the models, 
based on the information provided by the authors in the original papers. Thus, the scores are only 
weakly related to the scientific value of the models and mostly reflect the availability of information 
necessary for the short-listing of promising models, and their subsequent in-depth evaluation. 
   In Scheme 1:  Point A regards the clarity with which the algorithm is described; Point B regards 
the applicability domain; , Point C regards the statistical documentation; Point D regards the 
interpretability in mechanistic terms. In addition to the OECD principles, we considered in our 
scoring system also:  E1)  the number of data points used by the authors;  and E2) the number of 
chemicals of the same class present in the HPV inventory.  
   The relevance of E1 is self-evident. Regarding E2 it should be noted that, to assess the regulatory 
relevance of the (Q)SAR models, it is also important to weight the models against the pattern of use 
of chemicals in the real life. A realistic parameter is the presence of the various chemical classes in 
the European list of High Production Volume (HPV) chemicals. To this aim, we downloaded the 
list of EU HPV from the ESIS website, and we constructed the database of structures. This database 
of HPV structures was checked for the distribution of the chemical classes for which QSARs exist 
in the literature, and the results of this interrogation are the E2 scores.  
   The scores of the models are in Appendix 2. The identification number of each model is in 
Appendix 1; the repartition in chemical classes is reported in Appendix 1 as well. As additional 
information, Appendix 3 reports some documentation on the QSARs considered. 
   The models differed to a large extent in their characteristics. Figure 1 shows the distribution of the 
average scores. Figures 2 and 3 show the distribution of data points used by the authors to generate 
the QSARs for the individual chemical classes, and the non-local (Q)SARs, respectively. Thus the  
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Figure 1 
    
 
Figure 2 
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   Figure 3 
 
documentation in Appendix 2 provided a useful framework to short list a selection of promising 
models, that were characterized more in depth. It should be emphasized that the documentation in  
Appendix 2 was used in a flexible way. For example some models (e.g., Ref. 62, Ashby’ Alerts) 
cannot be given scores, since it was not derived in a formalized way and many criteria cannot be 
applied (the model comes from the non-formal accumulation of various sources of information on 
the mechanisms of action). However, for their scientific importance and impact on research such 
models cannot be excluded from consideration.  
   The flexible application of our subjective judgment to Appendix 2 produced the list of promising 
models reported in Table I. The numbers under Reference identify the models in Appendix 1.  
Detailed discussion and analysis of the individual models is in the following sections.  
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Table I:  Short listed (Q)SAR models 
 
Code  Chemical class Biological endpoints   Type  Reference 
            
QSAR1 Aromatic amines Salmonella mutagenicity TA98 Potency 4 
QSAR2       “           “          “                   “           TA100      “  4 
QSAR3       “           “  Mouse Carcinogenicity       “  23 
QSAR4       “           “  Rat Carcinogenicity        “  23 
QSAR5       “           “  Salmonella mutagenicity TA98 Activity Our Results 
QSAR6       “           “          “                   “           TA100      “    “     “ 
QSAR7       “           “  Rodent overall Carcinogenicity      “  24 
QSAR8       “           “  Rodent overall Carcinogenicity      “  24 
QSAR9 Nitroarenes  Salmonella mutagenicity TA98 Potency 32 
QSAR10       “           “          “                   “           TA100      “  33 
QSAR11 PAH    Rodent skin Carcinogenicity       “  47 
QSAR12 Aliphatic Aldehydes Salmonella mutagenicity TA100 Potency 60 
QSAR13       “           “         “                   “               “  Activity 60,61 
Ashby’ SAs         All  Genotoxic Carcinogenicity        “  62 
Bailey’s SAs           “         “                   “                   “  65 
Kazius’ SAs (1)        “  Salmonella Mutagenicity        “  63 
Kazius’ SAs (2)        “         “                   “                   “  64 
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2 The QSARs for congeneric classes of chemicals 
 
2.1 General considerations 
   The QSARs for classes of congeneric chemicals present in the literature were mainly generated 
through the application of the Hansch approach, or of Hansch-like discriminant analysis.  
    
   As preliminary assessment, we checked to what extent the existing QSARs cover the universe of 
chemicals in use in real life. For a first check, the compilation of Structural Alerts (SA) by John 
Ashby was used. This summarizes a large part of the knowledge on the chemical classes potentially 
able to produce cancer through genotoxic mechanisms, and was popularized pictorially as a “poly-
carcinogen” that includes many of known SAs (Ashby 1985) (see our adaptation in Figure 4a).  
 
Figure 4a 
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   Exploiting the Ashby’s poly-carcinogen, Figure 4b shows the chemical classes (circled SAs in the 
figure) for which QSARs are available in the literature. Some QSARs refer to chemical classes, 
which are not included in the Ashby’s pictorial representation.  
 
   Figure 4 
 
   Another way of checking the coverage of the existing QSARs was to assess the quantitative 
presence of the modeled classes in a real life scenario. To this aim, the list of the EU High 
Production Volume (HPV) chemicals was downloaded from the European chemical Substances 
Information System (ESIS) website (http://ecb.jrc.it/esis/.). A total of 1646 chemical structures out 
of 2747 HPV entries were generated for this study. The difference between the actual number of 
listed HPV chemicals and the coded structures was due to inability to codify some structures as well 
as to other difficulties, met in the identification of a substance when it is reported as a mixture or 
multi-component chemical with unclear or variable constitution.  
   The HPV chemical classes covered by QSARs are shown in Table II. It appears that the most 
represented classes are (in decreasing quantitative order): aromatic amines, halogenated aliphatics, 
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nitroaromatic compounds and aliphatic aldehydes. On the contrary, the polycyclic aromatic 
hydrocarbons, for which a number of QSARs exist, are a minority as pure chemicals in the EU HPV 
inventory. However, several of them are present as components of petrol products. 
   An additional information obtained by analysing the HPV database is that about one sixth of the 
structurally coded chemicals (~16%) on the EU HPV list triggers at least one SA (as given in 
Ashby’s compilation). This gives a rough estimation of the carcinogenic risk posed by the HPV 
chemicals, and of the extent of work necessary to evaluate this finding further.   
 
Table  II:  QSARs and EU HPV chemicals 
 
            Classes with QSARs   Number of  HPV chemicals 
 
  Aromatic amines     115  
  Halogenated aliphatics    113  
  Nitroaromatic compounds      42  
  Aliphatic aldehydes         33 
                       Epoxides      10 
  Polycyclic Aromatic Hydrocarbons     6  
  Lactones          3 
  Quinolines        1 
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2.2 Short listed QSARs 
 
   Among  the QSAR models for individual chemical classes, the models selected in Phase 1 of our 
survey are relative to the classes of aromatic amines,  nitroarenes, aliphatic aldehydes, and 
polycyclic aromatic hydrocarbons (PAH). As shown in Table II, the first 3 classes are those most 
represented among the HPV chemicals; on the other hand, the PAHs are poorly represented as pure 
and well defined  chemicals, but are widespread as mixtures or impurities. Halogenated aliphatics 
are one of top ranking classes in Table II;  however QSARs exist only for one endpoint 
(Aneuploidy in Aspergillus nidulans) that is valid scientifically, but is not included among the 
recognized regulatory methods (Refs. 51, 52, 53 in Appendix 1).   
   The models selected are described in the following references of Appendix 1: a)  Ref 4 
(mutagenicity) and Refs. 23 and 24 (carcinogenicity) for  aromatic amines;  b)  Refs. 32 and 33 
(mutagenicity) for nitroarenes; c) Refs. 60 and 61 (mutagenicity) for aliphatic aldehydes; d) Ref. 47 
(carcinogenicity) for PAHs. 
   Appendix 2 shows that all these models: a) have high ratings for Points A1, A2, A3 of Scheme 1 
(they provide a documentation sufficient for the models to be judged and analyzed in depth); b) 
have high ratings for Point D as well (they can be interpreted in mechanistic terms); and c) they rely 
on a sufficient number of data points, and they refer to some of the most represented classes among 
the HPV chemicals  (Table II). 
   The models are widely different for Points B and C of Scheme 1 (for example, some have 
information on external predictivity and some do not), but the information provided by the authors 
allowed us to re-check the results of the authors, and to complete the documentation.    
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2.3 Approach to the characterization of the short listed models 
 
   The characterization of the individual, short listed models follows the general scheme of OECD 
principles.  
 
A defined endpoint 
   The association of the model with a defined toxicity endpoint, addressed by an officially 
recognised test method (Annex V to Directive 67/548/EEC),  is reported. 
 
An unambiguous algorithm 
   The model given by the authors (together with the associated statistics) is reported.  
  
A defined domain of applicability 
   The applicability domain of the model is defined in terms of: a)  the structures to which it applies;  
and b) the range of the values of the descriptors in the model.  
   If this information is not reported by the authors, it is derived by us. 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The model is re-analyzed by us, and the concordance with the measures reported by the authors is 
given. When necessary, additional measures are calculated by us.  
 
    For Multiple Linear Regression (MLR) models,  the final overall characterization includes:  
r2; Adjusted r2;  q2.  
   The Cross-Validated r2 (q2) is = 1 – (sum of squares of the predictive residuals / sum of squares 
of the mean-centered response data). 
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  The mean Leverage (with SD) is used to assess if a model depends in a balanced way on all the 
data points (corresponding to low mean Leverage).    
 
   For discriminant models (Linear Discriminant Analysis and Canonical Discriminant Analysis),  
the final overall characterization includes: accuracy, sensitivity, and specificity, together with the 
Squared Canonical Correlation.  
   Accuracy is the percentage of all chemicals correctly identified by the model. Sensitivity is the 
percentage of biologically active (positive) chemicals correctly identified (calculated out of the total 
number of positives). Specificity is the percentage of biologically inactive (negative) chemicals 
correctly identified (calculated out of the total number of negatives).   
   The Squared Canonical Correlation is a measure of the correlation between the biological activity 
variable, and the linear combination of descriptor variables (produced either by Linear Discriminant 
Analysis or Canonical Discriminant Analysis) that best separates  the negatives from the positives.   
 
  For all models, the results of cross-validation is given. Three leave-many-out procedures were 
considered, leaving out: a) 10%; b) 25%; and c) 50% of the data set. Each procedure was applied 
ten times (by random selection of excluded chemicals; see more details in the following sections). 
For the MLR models, the average q2 (with Standard Deviation (SD)) is reported. For discriminant 
models, accuracy, sensitivity, and specificity (with SD) are reported.  
  
  If  the QSAR model is assessed by the authors for its predictivity of external compounds, the 
results are given  (together with the results of our re-checking). Otherwise, external data sets were 
sought by us, and (when available) the details on the external prediction exercise are reported.  
   For regression based models, the performance in external validation is expressed as correlation 
coefficient between experimental and predicted potency. An additional way of measuring the 
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prediction performance is the percentage of test chemicals correctly predicted within one log unit of 
potency. 
   For discriminant models, the external predictivity is measured as percentage of  test chemicals 
correctly predicted (accuracy).  
 
   Together with performance measures, the degree of concordance between the chemical domains 
of the training and test sets is reported in terms of: a) types of chemical structures; b) range of the 
values of the descriptors; c) chemical similarity indices.  
   For Point c), the training and test sets are combined and the overall Tanimoto similarity matrix is 
calculated with the computer software Leadscope. To smooth the effect of “weird” individual 
similarities and to filter the data by exploiting the global relationships patterns, an Euclidian 
distance matrix is calculated from the similarity matrix, and then subjected to Principal Component 
Analysis (Sneath 1983; Sneath & Johnson 1972) (Benigni 1993). Finally, the ranges of PC scores 
for the training and test sets are compared. 
 
A mechanistic interpretation, if possible 
   The concordance of the model with mechanistic knowledge is discussed. 
 
 
Abbreviations of general significance 
 
HOMO is the energy of the Highest Occupied Molecular Orbital,  
LUMO is the energy of the Lowest Unoccupied Molecular Orbital. 
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2.4 Characterization of the individual QSARs: results of the survey 
 
2.4.1 Aromatic amines 
 
   The aromatic amines are one of the chemical classes with the largest environmental and industrial 
impact,  and are the most represented class among the HPV chemicals (Table II). Consequently, this 
class has been the subject of a large number of QSAR analyses (Point 1.1 in Appendix 1), focusing 
both on their mutagenic (mainly) and carcinogenic effects.  
    The short listed QSARs are (Appendix 1):  
Ref. 4, mutagenic potency in Salmonella typhimurium TA98 and TA100; 
Ref.23, carcinogenic potency in rodents; 
Ref. 24, carcinogenic activity in rodents (two alternative models). 
   It should be noted that activity refers to the difference between active and inactive compounds, 
whereas potency refers to the gradation of the biological effect among the active chemicals only. As 
a matter of fact, for this chemical class the QSAR models for the mutagenic potency are different 
from those for the activity (Benigni, Andreoli & Giuliani 1994; Franke, Gruska, Giuliani & Benigni 
2001).  
   No models for the mutagenic activity of the aromatic amines exist in the literature, so a QSAR 
analysis was specifically performed by us for this project, based on the data in Ref. 4.  
   Refs. 4, 23, and 24 report some statistical measures of fitting and internal validation, however no 
check of external predictivity  are reported. Thus, in addition to internal validation checks (e.g., 
LMO, etc...) we found in the literature further chemicals suitable for external validation. For each 
model, the results of our analyses are reported here.       
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2.4.1.1 QSAR 1,  Ref. 4 in Appendix 1, Debnath et al., 1992, mutagenic potency in Salmonella 
typhimurium TA98 
 
A defined endpoint 
This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 4. The mutagenic potency in TA98 strain 
(+ S9 activation system) was modelled by: 
log TA98 = 1.08(±0.26) log P + 1.28(±0.64)HOMO – 0.73(±0.41)LUMO + 1.46(±0.56)IL + 
7.20(±5.4) (4.6) 
n = 88, r = 0.898 (r 2 = 0.806), s = 0.860, F 1,83 = 12.6 
   The mutagenic potency (log TA98) is expressed as log (revertants/nmol). High TA98 values 
indicate high mutagenic potency. The AM1 molecular orbital energies (HOMO and LUMO) are 
given in eV. IL is an indicator variable that assumes a value of 1 for compounds with three or more 
fused rings. 
 
A defined domain of applicability 
   The applicability domain of the model is defined explicitly by the authors in terms of  the 
structures to which it applies. The chemical set spans a large range of basic structures (aniline, 
biphenyl, anthracene, phenanthrene, fluorene, pyrene, fluoranthene, chrysene, quinoline, carbazole, 
phenazine) with one or two amine groups attached. 
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   A number of outliers were excluded from the analysis, but they do not point to general rules for 
defining the applicability domain.  
   
 The ranges of the chemical descriptors are not reported explicitly, and were derived by us:  
 
logP:             1.12        4.98; 
HOMO:      -10.018   -7.528; 
LUMO:         -1.691    0.722; 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient (see above). The data 
were re-analysed by us for this work. A Multiple Linear Regression (MLR) analysis reproduced the 
original QSAR equation, with 
r2 = 0.807;   
Adjusted r2 = 0.798;  
 q2 = 0.783. 
    
   The mean Leverage (with SD) is: 0.057  (0.035) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times. 
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = 0.707 (0.230) 
25%: q2 = 0.717 (0.115) 
50%: q2 = 0.772 (0.037) 
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   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. The external predictivity has been assessed by us on a set of amines retrieved 
from the open literature, and not used by the authors, with the following result: 
   External set, n = 33;     
   Correlation between experimental and predicted potency (logTA98) = 0.41; 
Percentage of chemicals correctly predicted within 1 logTA98 unit: 0.36.    
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
logP:        -0.61        6.71; 
HOMO:    -9.312      -7.861; 
LUMO:     -1.484       0.707; 
 
Range of chemical similarity indices (PCs): 
 Training set (N=88)  Test set (N=33) 
       Minimum         Maximum       Minimum         Maximum 
 
 Factor1 -1.292       1.424  -1.145       3.199 
 Factor2 -1.469       2.199  -1.314       1.836 
 Factor3 -1.930       2.174  -2.041       1.293 
 Factor4 -2.330       1.860  -1.567       1.988 
 
 
A mechanistic interpretation, if possible 
   Overall, the principal factor affecting the relative mutagenicity of the aminoarenes is their 
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hydrophobicity (logP). Mutagenicity increased with increasing HOMO values; this positive 
correlation is in agreement with the known mechanism of action, because compounds with higher 
HOMO values are easier to oxidize and should be readily bioactivated. For the negative correlation 
with LUMO, no simple explanation could be offered by the authors, but the same evidence was 
observed by other authors on different sub-sets of chemicals and relative to other end-points. 
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2.4.1.2 QSAR 2, Ref. 4 in Appendix 1, Debnath et al., 1992,  mutagenic potency in Salmonella 
typhimurium  TA100 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 4. The mutagenic potency in TA100 
strain (+ S9 activation system) was modelled by: 
log TA100 = 0.92(±0.23) log P + 1.17(±0.83)HOMO – 1.18(±0.44)LUMO + 7.35(±6.9) 
n = 67, r = 0.877 (r 2 = 0.769), s = 0.708, F 1,65 = 99.23 
The mutagenic potency (log TA100) is expressed as log (revertants/nmol). High TA100 values 
indicate high mutagenic potency. The AM1 molecular orbital energies (HOMO and LUMO) are 
given in eV. 
 
 
A defined domain of applicability 
   The applicability domain of the model is defined explicitly by the authors in terms of  the 
structures to which it applies. The chemical set spans a large range of basic structures (aniline, 
biphenyl, anthracene, phenanthrene, fluorene, pyrene, fluoranthene, chrysene, quinoline, carbazole, 
phenazine) with one or two amine groups attached.  
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  A number of outliers were excluded from the analysis, but they do not point to general rules for 
defining the applicability domain.  
   The ranges of the chemical descriptors are not reported explicitly, and were derived by us: 
 
logP:            1.16         4.98 
LUMO:     -1.330       0.702 
HOMO:     -8.695     -7.528 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient. The data have been re-
analysed by us. A Multiple Linear Regression (MLR) analysis reproduced the original QSAR 
equation, with 
r2 = 0.771;  
Adjusted r2 = 0.761;  
q2 = 0.740. 
    
   The mean Leverage (with SD) was: 0.060  (0.039) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times.   
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = 0.657  (0.143) 
25%: q2 = 0.740 (0.053) 
50%: q2 = 0.705 (0.007) 
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   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of amines 
retrieved from the open literature, and not used by the authors, with the following result: 
   External set, n = 29;     
   Correlation between experimental and predicted potency (logTA100) = 0.68; 
   Percentage of chemicals correctly predicted within 1 logTA100 unit = 0.57. 
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
logP:          0.09        5.12 
LUMO:    -0.850      0.684 
HOMO:    -8.945      -7.861 
 
Range of chemical similarity indices (PCs): 
             Training set (N=67)  Test set (N=29) 
       Minimum         Maximum       Minimum         Maximum 
 
Factor1  -1.097       0.952  -0.783       3.375 
Factor2  -1.319       2.213  -1.157       1.092 
Factor3  -1.415       2.347  -0.573       2.310 
Factor4  -1.883       2.504  -1.773       1.958 
 
 
A mechanistic interpretation, if possible 
   The model is very similar to that derived for the TA98 mutagenicity.  
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   TA100 QSAR lacks the IL term present in the TA98 model. The authors hypothesize that larger 
amines are more capable of inducing frameshift mutations (TA98 is specific for frame-shift 
mutations, whereas TA100 is specific for base-pairs substitution mutations), and that this effect is 
not accounted for by the increase of log P for increasing sizes of the molecules. 
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2.4.1.3 QSAR 3, Ref. 23 in Appendix 1, Benigni et al., 2000, carcinogenic potency in mouse 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (carcinogenicity), addressed by an 
officially recognised test method (Method B.32 Carcinogenicity test – Annex V to Directive 
67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 23. The carcinogenic potency in mouse was 
modelled by: 
 
BRM = 0.88(±0.27) log P × I (monoNH2) + 0.29(±0.20) log P × I (diNH2) + 1.38(±0.76) HOMO - 
1.28(±0.54) LUMO - 1.06(±0.34) ΣMR2,6 - 1.10(±0.80) MR3 - 0.20(±0.16) ES (R)  
+ 0.75(±0.75)I (diNH2) + 11.16(±6.68) 
n = 37, r= 0.907, r2 = 0.823, s= 0.381, F = 16.3, P<0.001  
 
where BRM = log(MW/TD50)mouse. TD50 is the daily dose required to halve the probability 
for an experimental animal of remaining tumorless to the end of its standard life span. High BRM 
values indicate high carcinogenic potency.  
ΣMR2,6 = sum of molar refractivity of substituents in the ortho-positions of the aniline ring;  
MR3 =  molar refractivity of substituents in the meta-position of the aniline ring;  
Es(R) = Charton’s substituent constant for substituents at the functional amino group; 
I (monoNH2) = 1 for compounds with only one amino group;  
I (diNH2) = 1 for compounds with more than one amino group. 
   MR and Es(R) are tabulated values, from (Hansch, Leo & Hoekman 1995). 
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   The PM3 (erroneously reported as AM1 in the paper) molecular orbital energies for HOMO and 
LUMO are given in eV. 
 
A defined domain of applicability 
   The applicability domain of the model is defined explicitly by the authors in terms of  the 
structures to which it applies. The chemical set spans a range of basic structures (anilines, 
biphenylamines, naphthylamines, aminofluorenes) with one or two amino groups attached.  
   The ranges of the chemical descriptors are not reported explicitly, and were derived by us: 
logP             0.20           4.25                    
HOMO    -10.265      -7.990 
LUMO      -1.997       0.438 
ΣMR2,6       0.180       2.640 
MR3            0.100       0.800  
ES (R)             0           6.00 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient. The data have been re-
analysed by us. A Multiple Linear Regression (MLR) analysis reproduced the original QSAR 
equation, with 
r2 = 0.821;  
Adjusted r2 = 0.767;  
q2 = 0.585. 
    
   The mean Leverage (with STD) was: 0.250  (0.157) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
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leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times.   
The average q2 (with Standard Deviation) were respectively: 
10%: q2 =  negative 
25%: q2 = 0.213 (0.881) 
50%: q2 = 0.268 (0.321) 
    
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of amines 
retrieved in the ISSCAN and CPDB databases, and not used by the authors, with the following 
result: 
 External set, n = 12;     
 Correlation between experimental and predicted potency (BRM) = 0.56; 
Percentage of chemicals correctly predicted within 1 log unit (BRM) = 0.58.   
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
logP              1.34       4.57                    
HOMO     -9.220      -8.043 
LUMO      -1.043       0.411 
ΣMR2,6       0.200       0.660 
MR3            0.100       0.560  
ES (R)            0            4.000 
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Range of chemical similarity indices (PCs): 
            Training set (N=36)  Test set (N=12) 
          Minimum         Maximum      Minimum       Maximum 
Factor1  -1.157       1.890  -0.918       1.816 
Factor2  -1.818       2.119  -1.653       2.176 
Factor3  -1.068       2.622  -0.908       1.586 
 
A mechanistic interpretation, if possible 
   The model is in agreement with the knowledge on the mechanism of action of the aromatic 
amines, whose major metabolic pathway requires oxidative activation of the chemicals. Moreover, 
the model agrees with those for the mutagenic potency in TA98 and TA100 Salmonella strains, with 
the same parameters in the same order of importance: hydrophobicity, HOMO, LUMO, and then a 
number of steric factors more specific for each individual experimental system.  
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2.4.1.4 QSAR 4, Ref. 23 in Appendix 1, Benigni et al., 2000, carcinogenic potency in rat 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (carcinogenicity), addressed by an 
officially recognised test method (Method B.32 Carcinogenicity test – Annex V to Directive 
67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 23. The carcinogenic potency in rat was 
modelled by: 
 
BRR = 0.35(±0.18) log P + 1.93(±0.48) I (Bi) + 1.15(±0.60)I (F) - 1.06(±0.53)I (BiBr)  
+ 2.75(±0.64)I (RNNO) - 0 .48(±0.30) 
n = 41, r= 0.933, r2 = 0.871, s= 0.398, F = 47.4, P<0.001 
 
where BRR = log(MW/TD50)rat. TD50 is the daily dose required to halve the probability 
for an experimental animal of remaining tumorless to the end of its standard life span. High BRR 
values indicate high carcinogenic potency.  
I (Bi) = 1 for biphenyls;  
I (BiBr) = 1 for biphenyls with a bridge between the phenyl rings;   
I (RNNO) = 1 for compounds with the group N(Me)NO (nitroso group, with a methyl substitution 
at the amino nitrogen);   
I (F) = 1 for fluoroamines. 
 
A defined domain of applicability 
   The applicability domain of the model is defined explicitly by the authors in terms of  the 
structures to which it applies. The chemical set spans a range of basic structures (anilines, 
biphenylamines, naphthylamines, aminofluorenes) with one or two amino groups attached. 
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   The ranges of the chemical descriptors are not reported explicitly, and were derived by us: 
 
logP:   0.23   3.73 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient. The data have been re-
analysed by us. A Multiple Linear Regression (MLR) analysis reproduced the original QSAR 
equation, with 
r2 = 0.871;  
Adjusted r2 = 0.852;  
q2 = 0.806. 
    
   The mean Leverage (with STD) was: 0.146  (0.118) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times.   
The average q2 (with Standard Deviation) were respectively: 
10%: q2 =  0.785 (0.261) 
25%: q2 = 0.721 (0.325) 
50%: q2 = 0.536 (0.255) 
 
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of amines 
retrieved in the ISSCAN and CPDB databases, and not used by the authors, with the following 
result: 
   External set, n = 7;     
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   Correlation between experimental and predicted potency (BRR) = 0.48; 
   Percentage of chemicals correctly predicted within 1 log unit (BRR) = 0.71.  
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
 
logP :    1.83   4.57 
 
Range of chemical similarity indices (PCs): 
 Training set (N=41)  Test set (N=7) 
         Minimum         Maximum     Minimum      Maximum 
 
 Factor1 -1.155       1.887  -1.015       1.643 
 Factor2 -1.754       1.797  -1.271       1.353 
 Factor3 -2.373       1.774  -0.651       0.973 
 
A mechanistic interpretation, if possible 
   The logP and steric factors in the model can be interpreted in mechanistic terms, and appear also 
in the models for the carcinogenic potency in mouse and for the mutagenic potency. However, the 
electronic reactivity terms HOMO and LUMO present in the above equations are missing in this 
equation.     
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2.4.1.5 QSAR 5, our unpublished results, mutagenic activity in Salmonella typhimurium TA98 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
    
   The data on the mutagenic activity on the TA98 strain are in Ref. 4. The  QSAR model was 
generated expressly by us for this project.  The mutagenicity data (yes/no) were analysed with 
Canonical Discriminant Analysis. The mutagenic activity  was modelled by: 
w =  –0.32 HOMO + 0.97 LUMO - 0.28 MR5 + 0.27 MR3 + 0.50 MR6 
w(mean,Class1) = -0.31    N1 = 21 
w(mean,Class2) = 1.39     N2 = 94 
 
 
where N1 = number of non-mutagens (Class 1) and N2 = number of mutagens (Class 2). The 
threshold is the midpoint between w(mean,Class1) and  w(mean,Class2). 
 The AM1 molecular orbital energies for HOMO and LUMO are given in eV. MR5 , MR3  and MR6 
are the MR contributions of substituents in position 3, 5, and 6 to the amino group. 
   The coefficients in the equation are standardized, so they reflect the relative importance of the 
descriptors in the discrimination. To apply this equation to an external test set, one has to 
standardize the values of the descriptors according to the training set (i.e., subtract the mean and 
divide by the SD of the training set).   
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   The equation correctly reclassified 82.6% (Accuracy) of the compounds (Class1, nonmutagens , 
95.2% (Specificity; Class2, mutagens, 79.8% (Sensitivity)).   
Squared Canonical Correlation = 0.31 
. 
 
A defined domain of applicability 
   The applicability domain of the model can be inferred from the structures to which it applies. The 
chemical set spans a large range of basic structures (aniline, biphenyl, anthracene, phenanthrene, 
fluorene, pyrene, fluoranthene, chrysene, quinoline, carbazole, phenazine) with one or two amino 
groups attached.  
   The ranges of the chemical descriptors are:  
 
HOMO:        -10.020     -7.528    
LUMO:         -1.691      0.722    
MR5                 0.000      0.800    
MR3                 0.100      3.170    
MR6                 0.056      1.500    
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
     
   The goodness-of-fit of the model is reported above (accuracy, sensitivity and specificity).    
 
We also performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. In addition, each procedure was applied 
in two different ways, by generating test sets with the following characteristics: 1) Option 1: with 
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the same proportion Class1/Class2 present in the whole sample of chemicals; 2) Option 2: without 
the above constraint. Each procedure was applied ten times. 
 
 
 
 
Option 1 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:   81.1  90.0   82.7 
-25%:   77.1  96.0   80.3 
-50%:   77.9  84.5   79.1 
 
 
Option 2 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:   82.6  100.0   86.7 
-25%:   79.1  91.5   81.4 
-50%:   75.9  83.0   76.7 
 
 
   The QSAR model has been assessed by us for its predictivity of the activity of external 
compounds (retrieved in the open literature), with the following result: 
   External set, n = 54;     
   Percentage of chemicals correctly predicted  = 0.63   
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
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Range of descriptors values of the test set: 
 
HOMO:        -10.212     -7.861    
LUMO:         -2.028      0.709    
MR5                 0.100      0.740    
MR3                 0.100      0.800    
MR6                 0.100      1.500    
 
Range of chemical similarity indices (PCs): 
                     Training set (N=115)  Test set (N=54) 
       Minimum         Maximum       Minimum         Maximum 
 
Factor1  -1.317       0.997  -1.203       3.085 
Factor2  -1.452       2.070  -1.414       1.724 
Factor3  -1.721       2.490  -1.543       0.957 
Factor4  -2.085       2.461  -2.023       1.609 
 
A mechanistic interpretation, if possible 
   Whereas the principal factor that affects the relative mutagenicity (potency) of the aminoarenes is  
their hydrophobicity (logP), followed by electronic factors (HOMO and LUMO) and then steric 
factors, the model for the yes/no activity shows no influence of logP. This indicates that the 
potential to be active depends on a threshold of reactivity (HOMO and LUMO), and on the steric 
hindrance at substitution positions 3, 5, and 6 of the ring. The parameters in the model are 
mechanistically linked to requirements for metabolic activation.  
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2.4.1.6 QSAR 6, our unpublished results, mutagenic activity in Salmonella typhimurium TA100 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
 
An unambiguous algorithm 
    
   The data on the mutagenic activity on the TA100 strain are in Ref. 4. The  QSAR model was 
generated expressly by us for this project.  The mutagenicity data (yes/no) were analysed with 
Canonical Discriminant Analysis. The mutagenic activity  was modelled by: 
w =  –0.65 HOMO + 0.69 LUMO + 0.39 MR2 + 0.39 MR3 + 0.46 MR6 
w(mean,Class1) = 1.04 N1 = 43 
w(mean,Class2) = -0.61 N2 = 73 
 
where N1 = number of non-mutagens (Class 1) and N2 = number of mutagens (Class 2). The 
threshold is the midpoint between w(mean,Class1) and  w(mean,Class2). 
  The AM1 molecular orbital energies for HOMO and LUMO are given in eV. MR2 , MR3 ,  MR6 
are the MR contributions of substituents in position 2, 3, and 6 to the amino group. 
   The coefficients in the equation are standardized, so they reflect the relative importance of the 
descriptors in the separation. To apply this equation to an external test set, one has to standardize 
the values of the descriptors according to the training set (i.e., subtract the mean and divide by the 
SD of the training set).   
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   The equation correctly reclassified 78.6% (Accuracy) of the compounds (Class1, nonmutagens 
,88.6% (Specificity); Class2, mutagens, 72.6% (Sensitivity)).   
Squared Canonical Correlation: 0.39. 
 
A defined domain of applicability 
   The applicability domain of the model can be inferred from the structures to which it applies. The 
chemical set spans a large range of basic structures (aniline, biphenyl, anthracene, phenanthrene, 
fluorene, pyrene, fluoranthene, chrysene, quinoline, carbazole, phenazine) with one or two amino 
groups attached.  
   The ranges of the chemical descriptors are:  
 
HOMO      -9.032      -7.528 
LUMO       -1.330       0.722 
MR2           0.090        2.980 
MR3           0.100        2.980 
MR6                 0.056          1.500 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
     
   The goodness-of-fit of the model is reported above (accuracy, sensitivity and specificity).    
We also performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. In addition, each procedure was applied 
in two different ways, by generating test sets with the following characteristics: 1) Option 1: with 
the same proportion Class1/Class2 present in the whole sample of chemicals; 2) Option 2: without 
the above constraint. Each procedure was applied ten times. 
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Option 1: 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:   57.1  80.0   65.5 
-25%:   71.7  93.0   79.3 
-50%:   73.2  80.9   76.1 
 
 
Option 2: 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:   69.7  96.8   78.3 
-25%:   68.4  86.6   75.9 
-50%:   71.2  80.5   74.7 
 
 
   The QSAR model has been assessed by us for its predictivity of the activity of external 
compounds (retrieved in the open literature), with the following result: 
   External set, n = 52;     
   Percentage of chemicals correctly predicted  = 0.69   
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
HOMO       -10.212      -7.861 
LUMO        -2.028        0.709 
MR2                0             1.960 
MR3            0.100          0.800 
MR6                    0.100            1.500 
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Range of chemical similarity indices (PCs): 
 
                     Training set (N=116)  Test set (N=52) 
       Minimum         Maximum      Minimum         Maximum 
 Factor1 -1.078       1.011  -0.969       3.109 
 Factor2 -1.600       1.681  -1.536       1.537 
 Factor3 -2.064       1.865  -2.125       0.730 
 Factor4 -1.296       2.522  -1.499       1.302 
 Factor5 -1.722       2.049  -1.063       2.251 
 
 
A mechanistic interpretation, if possible 
  Whereas the principal factor that affects the relative mutagenicity (potency) of the aminoarenes is  
their hydrophobicity (logP), followed by electronic factors (HOMO and LUMO) and then steric 
factors, the model for the yes/no activity shows no influence of logP. This indicates that the 
potential to be active depends on a threshold of reactivity (HOMO and LUMO), and on the steric 
hindrance at substitution positions 2, 3, and 6 of the ring. The parameters in the model are 
mechanistically linked to requirements for metabolic activation.   
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2.4.1.7 QSAR 7, Ref. 24 in Appendix 1(Eq. 4 in the paper), Franke et al., 2001,  carcinogenic 
activity in rodents (overall) 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (carcinogenicity), addressed by an 
officially recognised test method (Method B.32 Carcinogenicity test – Annex V to Directive 
67/548/EEC). 
 
An unambiguous algorithm 
   The data and the QSAR model is in Ref. 24, Eq. 4. The rodent carcinogenicity data (overall yes/no 
score from four experimental groups: rat, mouse, male, female) were analysed with Canonical 
Discriminant Analysis. The carcinogenicity was modelled by: 
w = -2.86 L(R ) + 2.65 B5( R) –1.16 HOMO + 1.76 LUMO + 0.40 MR3 + 0.58 MR5 + 0.54 MR6 
–1.55 I(An) + 0.74 I(NO2) –0.55 I(BiBr) 
w(mean,Class1) = -1.56 N1 = 13 
w(mean,Class2) = 0.38 N2 = 53 
 
where N1 = number of non-carcinogens (Class 1) and N2 = number of carcinogens (Class 2). The 
threshold is the midpoint between w(mean,Class1) and  w(mean,Class2). 
   L(R ) (length) and B5( R) (maximal width) are Sterimol parameters (tabulated in (Verloop 1987)). 
The PM3 (erroneously AM1 in the paper) molecular orbital energies for HOMO and LUMO are 
given in eV. MR3 , MR5 , MR6 are the MR contributions of substituents in position 3, 5, and 6 to the 
amino group. I(An), I(NO2), and I(BiBr) are indicator variables that take value = 1 for anilines, for 
the presence of a NO2 group, and for biphenyls with a bridge between the phenyl rings, 
respectively. 
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   The coefficients in the equation are standardized, so they reflect the relative importance of the 
descriptors in the separation. Thus to apply this equation to an external test set, one has to 
standardize the values of the descriptors according to the training set (i.e., subtract the mean and 
divide by the SD of the training set).   
   The equation correctly reclassified 87.9% (Accuracy) of the compounds (Class1, noncarcinogens , 
84.6% (Specificity); Class2, carcinogens, 88.7% (Sensitivity)).   
Squared Canonical Correlation (our calculation): 0.38.  
 
 
A defined domain of applicability 
   Regarding the applicability domain of the model, the original paper lists the basic substructures 
to which it applies (aniline, biphenyl, naphthalene, fluorene) with one or two amino groups 
attached. The ranges of chemical descriptors values are not reported explicitly, and were determined 
by us: 
 
L(R ):             2.06       5.97 
B5( R):          1.00        4.04 
HOMO:      -9.544      -7.989 
LUMO:       -1.594      0.438 
MR3:            0.10         0.80 
MR5:             0.09        1.49 
MR6:             0.09         0.60 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
   The goodness-of-fit reported by the authors consists of the accuracy, sensitivity and specificity 
parameters (see above). Our re-analysis of the original data reproduced the reported QSAR equation 
and statistical parameters. 
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   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. In addition, each procedure was applied 
in two different ways, by generating test sets with the following characteristics: 1) Option 1: with 
the same proportion Class1/Class2 present in the whole sample of chemicals; 2) Option 2: without 
the above constraint. Each procedure was applied ten times. 
Option 1: 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:   76.0   70.0   75.0 
-25%:   79.2   70.0   77.5 
-50%:   76.7   70.0   75.3 
 
Option 2: 
  
 Sensitivity  Specificity   Accuracy 
 
-10%:  89.3   70.0   85.7 
-25%:  80.4   82.5   80.0 
-50%:  80.7   66.5   78.5 
 
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of amines 
retrieved in the ISSCAN and CPDB databases, and not used by the authors, with the following 
result: 
   External set, n = 27;     
   Percentage of chemicals correctly predicted  = 0.67   
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: 
The basic structures of the test set chemicals were checked, and are within the range of the training 
set.  
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Range of descriptors values of the test set: 
 
L(R ):    2.060           10.790 
B5( R):  1.000            7.990 
HOMO:  -9.416         -8.043 
LUMO  -1.304           0.461 
MR3:      0.100           0.800 
MR5:       0.100          0.740 
MR6:      0.100           0.600 
 
Range of chemical similarity indices (PCs): 
 
          Training set (N=66)  Test set (N=28) 
        Minimum         Maximum       Minimum         Maximum 
Factor1  -1.160       2.041  -1.020       1.952 
Factor2  -1.678       2.007  -1.688       2.176 
Factor3  -1.914       1.618  -2.016       1.777 
Factor4  -1.892       1.997  -1.932       1.172 
 
 
A mechanistic interpretation, if possible 
   Whereas the principal factor that affects the relative carcinogenicity (potency) of the aminoarenes 
is  their hydrophobicity (logP), followed by electronic factors (HOMO and LUMO) and then steric 
factors, the model for the yes/no activity shows no influence of logP. This indicates that the 
potential to be active depends on a threshold of reactivity (HOMO and LUMO), and on the steric 
hindrance at substitution positions 3, 5, and 6 of the ring, together with steric hindrance due to 
bulky substituents to the nitrogen. The parameters in the model are mechanistically linked to 
requirements for metabolic activation. 
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2.4.1.8  QSAR 8, Ref. 24 (Eq. 5 in the paper) in Appendix 1, Franke et al., 2001, 
carcinogenic activity in rodents (overall) 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (carcinogenicity), addressed by an 
officially recognised test method (Method B.32 Carcinogenicity test – Annex V to Directive 
67/548/EEC). 
 
An unambiguous algorithm 
 
   The data and the QSAR model is in Ref. 24, Eq. 5. The rodent carcinogenicity data (overall 
yes/no score from four experimental groups: rat, mouse, male, female) were analysed with 
Canonical Discriminant Analysis. The carcinogenicity was modelled by: 
w =  -3.42 L(R ) + 3.11 B5( R) –1.57 HOMO + 2.19 LUMO + 0.66 MR3 + 0.65 MR5 + 0.54 MR6 
–1.64 I(An) + 0.57 I(NO2) –0.63 I(BiBr) 
w(mean,Class1) = -2.04    N1 = 12 
w(mean,Class2) = 0.47     N2 = 52 
 
where N1 = number of non-carcinogens (Class 1) and N2 = number of carcinogens (Class 2). The 
threshold is the midpoint between w(mean,Class1) and  w(mean,Class2). 
   L(R ) (length) and B5( R) (maximal width) are Sterimol parameters (tabulated in (Verloop 1987)). 
The PM3 (erroneously AM1 in the paper) molecular orbital energies for HOMO and LUMO are 
given in eV. MR3 , MR5 , MR6 are the MR contributions of substituents in position 3, 5, and 6 to the 
amino group. I(An), I(NO2), and I(BiBr) are indicator variables that take value = 1 for anilines, for 
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the presence of a NO2 group, and for biphenyls with a bridge between the phenyl rings, 
respectively. 
   The coefficients in the equation are standardized, so they reflect the relative importance of the 
descriptors in the separation. Thus to apply this equation to an external test set, one has to 
standardize the values of the descriptors according to the training set (i.e., subtract the mean and 
divide by the SD of the training set).   
 
   The equation correctly reclassified 93.7.% (Accuracy) of the compounds (Class1, noncarcinogens, 
92.7% (Specificity); Class2, carcinogens, 94.2% (Sensitivity)).   
Squared Canonical Correlation (our calculation): 0.50. 
 
   This equation was obtained after exclusion from the training set of two compounds misclassified 
by QSAR7 (Eq. 4 in Ref.  24). The exclusion of the two chemicals improved both the goodness of 
fit and the external predictivity (see below). 
 
A defined domain of applicability 
   Regarding the applicability domain of the model, the original paper lists the basic substructures 
to which it applies (aniline, biphenyl, naphthalene, fluorene) with one or two amino groups 
attached. The ranges of chemical descriptors values are not reported explicitly, and were determined 
by us: 
 
L(R )         2.060       5.970 
B5( R)       1.000       4.040 
HOMO    -9.544      -7.990 
LUMO     -1.594       0.438 
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MR3         0.100       0.800 
MR5         0.090       1.490 
MR6              0.090       0.600 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
  
      The goodness-of-fit reported by the authors consists of the accuracy, sensitivity and specificity 
parameters (see above). Our re-analysis of the original data reproduced the reported QSAR equation 
and statistical parameters. 
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. In addition, each procedure was applied 
in two different ways, by generating test sets with the following characteristics: 1) Option 1: with 
the same proportion Class1/Class2 present in the whole sample of chemicals; 2) Option 2:  without 
the above constraint. Each procedure was applied ten times. 
 
Option 1: 
Sensitivity  Specificity   Accuracy 
 
10%:   80.0   70.0   78.3 
25%:    84.6   80.0   83.8 
50%:    83.8   81.7   83.4 
 
  
 
 
Option 2: 
Sensitivity  Specificity   Accuracy 
 
10%:   85.2   71.7   81.7 
25%:   79.9   76.2   78.1 
50%:   82.5   73.1   80.3 
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 The QSAR model has not been assessed by the authors for its predictivity of the activity of external 
compounds. Thus the external predictivity has been assessed by us on a set of amines retrieved in 
the ISSCAN and CPDB databases, and not used by the authors, with the following result: 
   External set, n = 27;     
   Percentage of chemicals correctly predicted  = 0.70   
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
 
L(R )          2.060        10.790 
B5( R)       1.000         7.990 
HOMO      -9.416      -8.043 
LUMO       -1.304       0.461 
MR3            0.100         0.800 
MR5            0.100         0.740 
MR6                  0.100       0.600 
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Range of chemical similarity indices (PCs): 
 
                 Training set (N=64)   Test set (N=28) 
               Minimum         Maximum  Minimum         Maximum 
Factor1  -1.157       2.021  -1.002       1.933 
Factor2  -1.765       1.854  -1.742       2.017 
Factor3  -1.852       1.836  -1.938       2.040 
Factor4  -1.883       2.038  -1.946       1.154 
 
A mechanistic interpretation, if possible 
   Whereas the principal factor that affects the relative carcinogenicity (potency) of the aminoarenes 
is  their hydrophobicity (logP), followed by electronic factors (HOMO and LUMO) and then steric 
factors, the model for the yes/no activity shows no influence of logP. This indicates that the 
potential to be active depends on a threshold of reactivity (HOMO and LUMO), and on the steric 
hindrance at substitution positions 3, 5, and 6 of the ring, together with steric hindrance due to 
bulky substituents to the nitrogen. The parameters in the model are mechanistically linked to 
requirements for metabolic activation.  
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2.4.2  Nitroarenes 
 
   Nitroarenes are highly represented among the EU HPV’s (Table II). For this class, only models 
for the mutagenic potency in Salmonella typhimurium are available in the literature. Beside revising 
two short listed models (Refs. 32 and 33 in Appendix 1), we found in the literature a set of further 
chemicals suitable for assessing their external predictivity: the results are reported below. 
 
2.4.2.1 QSAR 9,  Ref. 32, mutagenic potency in Salmonella typhimurium TA98 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 32. The mutagenic potency in TA98 strain 
(without S9 activation system) was modelled by: 
log TA98 = 0.65(±0.16) log P  - 2.90(±0.59) log  (β 10 logP + 1) – 1.38(±0.25)LUMO  
                   + 1.88 (±0.39)Il – 2.89 I a (±0.81) – 4.15(±0.58) 
n =188, r = 0.900 (r 2 = 0.810), s = 0.886, logP 0 = 4.93,  log β = 5.48, F 1,181 = 48.6 
 
   The mutagenic potency (log TA98) is expressed as log (revertants/nmol); increasing TA98 values 
correspond to increasing mutagenic potency. The AM1 molecular orbital energies are given in eV.   
Il  is an indicator variable that assumes a value of 1 for compounds with three or more fused rings;  
Ia  takes the value of 1 for five examples of acenthrylenes. 
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A defined domain of applicability 
   The applicability domain of the model is defined by the authors in terms of  the structures to 
which it applies. The chemical set spans a very large range of basic structures (e.g., benzene to 
coronene and many different types of heterocycles) which are listed in the original paper.    
    
The ranges of the chemical descriptors are not reported explicitly, and were derived by us:  
LUMO:    -3.770      -0.530 
logP.          -0.02         7.84 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient and related statistics (see 
above). The data were re-analysed by us for this work. A Multiple Linear Regression (MLR) 
analysis reproduced the original QSAR equation, with 
r2 = 0.811;   
Adjusted r2 = 0.805;  
 q2 = 0.890. 
   The Cross-Validated r2 (q2) is = 1 – (sum of squares of the predictive residuals / sum of squares 
of the mean-centered response data). 
   The mean Leverage (with STD) was: 0.032  (0.040) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times. 
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = 0.795 (0.064) 
25%: q2 = 0.796 (0.041) 
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50%: q2 = 0.788 (0.023) 
 
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of nitroarenes 
retrieved in the literature, and not used by the authors, with the following result: 
   External set, n = 30;     
   Correlation between experimental and predicted potency (logTA98) = -0.23; 
   Percentage of chemicals correctly predicted within 1 logTA98 unit = 0.43.    
    
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
 
LUMO:   -1.815      -0.870 
logP          0.28       7.59 
 
Range of chemical similarity indices (PCs): 
          Training set (N=188)   Test set (N=30) 
       Minimum         Maximum        Minimum         Maximum 
 
Factor1  -1.026       2.630  -0.931       0.893 
Factor2  -1.547       2.853  -0.335       2.219 
Factor3  -1.902       2.800  -1.565       2.027 
Factor4  -2.456       1.418  -2.485       1.267 
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A mechanistic interpretation, if possible 
   Overall, the principal factor affecting the relative mutagenicity of the nitroarenes was their 
hydrophobicity (logP). Mutagenicity increased with decreasing LUMO values; this negative 
correlation is in agreement with the known mechanism of action, because compounds with lower 
LUMO values are easier to reduce and should be readily bioactivated.  
   The similarity with QSAR 10 (see infra) adds credibility to this model (lateral validation).   
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2.4.2.2 QSAR 10,  Ref. 33, mutagenic potency in Salmonella typhimurium TA100 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 33. The mutagenic potency in TA100 strain 
(without S9 activation system) was modelled by: 
log TA100 = 1.20(±0.15) log P  - 3.40(±0.74) log  (β 10 logP + 1) – 2.05(±0.32)LUMO  
                    – 3.50(±0.82) I a   + 1.86(±0.74) I ind – 6.39(±0.73) 
n =117, r = 0.886 (r 2 = 0.785), s = 0.835, logP0 = 5.44,  log β = -5.7,  F1,110 = 24.7 
 
   The mutagenic potency (log TA100) is expressed as log (revertants/nmol); increasing TA100 
values correspond to increasing mutagenic potency. The AM1 molecular orbital energies are given 
in eV.   Iind  is an indicator variable that assumes a value of 1 for six examples of 1- and 2-
methylindazoles; I a  takes the value of 1 for five examples of acenthrylenes. 
 
 
A defined domain of applicability 
   The applicability domain of the model is defined by the authors in terms of  the structures to 
which it applies. The chemical set spans a very large range of basic structures (e.g., benzene to 
coronene and many different types of heterocycles) which are listed in the original paper.    
   The ranges of the chemical descriptors are not reported explicitly, and were derived by us:  
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LUMO:      -3.406     -0.690 
logP:            -0.47        7.84 
 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient and related statistics (see 
above). The data were re-analysed by us for this work. A Multiple Linear Regression (MLR) 
analysis reproduced the original QSAR equation, with 
r2 = 0.785;   
Adjusted r2 = 0.775;  
 q2 = 0.768. 
   The Cross-Validated r2 (q2) is = 1 – (sum of squares of the predictive residuals / sum of squares 
of the mean-centered response data). 
   The mean Leverage (with STD) was: 0.051  (0.070) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times. 
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = 0.726 (0.514) 
25%: q2 = 0.756 (0.058) 
50%: q2 = 0.757 (0.033) 
    
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds. Thus the external predictivity has been assessed by us on a set of nitroarenes 
retrieved in the literature, and not used by the authors, with the following result: 
   External set, n = 25;     
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   Correlation between experimental and predicted potency (logTA100) = 0.36; 
   Percentage of chemicals correctly predicted within 1 logTA100 unit = 0.32.     
 
Characterization of the test set, in relation to the applicability domain of the training set 
 
Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
Range of descriptors values of the test set: 
 
LUMO:    -1.830      -0.704 
logP           0.23         7.59 
 
Range of chemical similarity indices (PCs): 
          Training set (N=117)  Test set (N=25) 
       Minimum         Maximum         Minimum         Maximum 
 
Factor1  -1.571       1.706  -0.192       1.718 
Factor2  -1.457       2.315  -0.619       1.109 
Factor3  -1.514       3.234  -1.589       0.610 
Factor4  -1.955       2.967  -2.391       0.030 
 
 
A mechanistic interpretation, if possible 
   Overall, the principal factor affecting the relative mutagenicity of the nitroarenes was their 
hydrophobicity (logP). Mutagenicity increased with decreasing LUMO values; this negative 
correlation is in agreement with the known mechanism of action, because compounds with lower 
LUMO values are easier to reduce and should be readily bioactivated.  
   The similarity with QSAR 9 adds credibility to this model (lateral validation).  
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2.4.3 Polycyclic aromatic hydrocarbons (PAH) 
 
   The PAH –as pure chemicals- are poorly represented among the EU HPV’s (Table II), however 
they are widely diffused in mixtures (e.g., in petrol products).  Only models for the (skin) 
carcinogenicity of the PAHs were retrieved in the literature. No external data sets, with a coherent 
measure of biological activity, were identified for assessing predictivity.  
 
 
2.4.3.1 QSAR 11,  Ref. 47 in Appendix 1, Zhang et al., 1992,  Skin carcinogenicity in rodents 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (carcinogenicity), addressed by an 
officially recognised test method (Method B.32 Carcinogenicity test – Annex V to Directive 
67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR models are reported in Ref. 47. The skin carcinogenic potency in mice was 
modelled by: 
log Iball = 0.55(±0.09) log P – 1.17(±0.14) log (. 10log P + 1) + 0.39(±0.11)LK  
                   + 0.47(±0.26)HOMO + 1.93(±2.4) 
n = 161, r = 0.845 (r 2 = 0.714), s = 0.350, log . = –6.81, F 1,155 = 12.8 
where: 
Iball index = (tumor incidence) (100%) / (mean latent period in days)  
with 
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tumor incidence = (number of animal with tumors) / (number of animals alive when the first tumor 
appears); 
   LK is an indicator variable assigned a value 1 for all chemicals where a substituent is attached to a 
L or K region (Structure 1). 
   The electronic parameter HOMO was calculated with the AM1 procedure. 
 
Structure 1:   L, K and Bay regions of PAHs 
 
 
 
A defined domain of applicability 
   The model applies to a very large range of structures (both homo and heterocyclic); details on the 
structural variations are in the original paper. 
   The ranges of chemical descriptors values are not reported explicitly in the paper, and are as 
follows: 
logP:               3.30      11.01 
HOMO:        -9.13      -7.54 
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Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient and related statistics (see 
above). The data were re-analysed by us for this work. A Multiple Linear Regression (MLR) 
analysis reproduced the original QSAR equation, with 
r2 = 0.713;   
Adjusted r2 = 0.705;  
 q2 = 0.689. 
    
   The mean Leverage (with SD) was: 0.031  (0.030) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times. 
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = 0.687 (0.113) 
25%: q2 = 0.712 (0.075) 
50%: q2 = 0.663 (0.061) 
 
   The QSAR model has not been assessed by the authors for its predictivity of the activity of 
external compounds; however, we were not able to find in the literature a set of external chemicals 
suitable for assessing the predictivity of the model.  
 
A mechanistic interpretation, if possible 
   The QSAR model is in agreement with the theories regarding K-region (9,10 bond in 
phenanthrene and analogs) and L-region (region between the C14 and C17 positions of 
phenanthrene) activation as being responsible for carcinogenicity of these compounds. A positive 
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coefficient of LK means that a substitution in an L or K region inhibits metabolism at these points 
and then leads to increased potency of these congeners, other factors being equal. 
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2.4.4 α,β-Unsaturated aliphatic aldehydes 
 
   Aliphatic aldehydes are widely diffused among the EU HPVs. Here we analyze models for the 
mutagenic potency, and mutagenic activity of the α,β-unsaturated aliphatic aldehydes (Refs 60 and 
61). The external predictivity was assessed by the authors of the models. 
 
2.4.4.1 QSAR 12,  Ref. 60 in Appendix 1, Benigni et al., 2003, mutagenic potency in Salmonella 
typhimurium TA100 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
An unambiguous algorithm 
   The data and QSAR model are reported in Ref. 60. The mutagenic potency in TA100 strain 
(without S9 activation system) was modelled by: 
logTA100 =  – 4.58430 LUMO –3.66205 MR  + 72.46140 Ccarb + 2.55239 logP  
                   + 13.09442 Cβ –12.61592 
n =17;  r2 = 0.84;  cross-validated r2 (q2) = 0.40;   
 
   The mutagenic potency (log TA100) is expressed as log (revertants/µmol). The PM3 molecular 
orbital energies are given in eV.  Ccarb and Cβ are the partial charges on the carbonilic and  β carbon 
atoms. 
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A defined domain of applicability 
   The applicability domain of the model is restricted to  α,β-unsaturated aldehydes with both 
aliphatic and aromatic substitutions.   
   The ranges of the chemical descriptors are not reported explicitly, and were derived by us:  
 
LUMO    -1.159      -0.101 
MR        1.655         5.171 
Ccarb       0.307         0.333 
logP       -0.010        2.742 
Cβ           -0.149       0.036 
 
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
    The goodness-of-fit reported by the authors is the correlation coefficient and related statistics (see 
above). The data were re-analysed by us for this work. A Multiple Linear Regression (MLR) 
analysis reproduced the original QSAR equation, with 
r2 = 0.841;   
Adjusted r2 = 0.767;  
 q2 = 0.387. 
 
   The mean Leverage (with STD) was: 0.253  (0.190) 
   
   We performed cross-validation on the data. Three leave-many-out procedures were applied, 
leaving out: a) 10%; b) 25%; and c) 50% of the training set. Each procedure was applied ten times. 
The average q2 (with Standard Deviation) were respectively: 
10%: q2 = negative 
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25%: q2 = negative 
50%: q2 = negative 
    
 
   Regarding external predictivity, in a subsequent paper (Ref. 61) more chemicals of the same class 
were tested: only two out five resulted to be mutagenic, so a test of external predictivity is not 
representative given the small size of the sample. We were not able to retrieve in the literature 
further external chemicals with test data.  
 
A mechanistic interpretation, if possible 
   The mutagenic potency in TA100 increases with decreasing values of LUMO and MR. Low 
LUMO values indicate a high propensity to accept electrons, hence high electrophilic reactivity. 
MR parametrizes the bulkiness of the molecules; the smaller the molecules, the higher their 
capacity to interact. Moreover, the mutagenic potency is favored by increasing partial charges on 
both the carbonyl and β carbons, and by increasing hydrophobicity (logP). Overall, the result of the 
QSAR analysis is concordant with the scientific evidence on mechanism of action of these 
chemicals, which react as direct electrophiles to form adducts with DNA and proteins (with the β 
and carbonyl carbons being the points of attack). 
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2.4.4.2 QSAR 13, Refs. 60 and 61 in Appendix 1, Benigni et al., 2003; 2005, mutagenic activity in 
Salmonella typhimurium TA100 
 
A defined endpoint 
   This QSAR is associated with a defined toxicity endpoint (genetic mutation), addressed by an 
officially recognised test method (Method B.13/14 Mutagenicity – Reverse Mutation test using 
bacteria – Annex V to Directive 67/548/EEC). 
 
 
An unambiguous algorithm 
    
   The data on the mutagenic activity on the TA100 strain are in Ref. 60. The mutagenicity data 
(yes/no) were analysed with Stepwise Linear Discriminant Analysis. The mutagenic activity  was 
modelled by equations relative to negatives and positives, respectively: 
wnegative =  –47.13 + 38.25 MR – 31.78 logP + 30.47 LUMO  
wpositive =  –20.52 + 25.42 MR – 21.45 logP + 19.78 LUMO  
n.negatives = 3; n.positives = 17.  
 
 
   The PM3 molecular orbital energies are given in eV.   
   To estimate the activity of external chemicals, the two equations are applied and the chemical is 
assigned to the class for which the resulting w value is highest.  
 
 
 
   The equation correctly reclassified 100% of the compounds; a Leave-One-Out cross-validation 
reclassified correctly 85% of the compounds.  
Squared Canonical Correlation = 0.61. 
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A defined domain of applicability 
   The applicability domain of the model is restricted to  α,β-unsaturated aldehydes with both 
aliphatic and aromatic substitutions.   
   The ranges of chemical descriptors values are not reported explicitly in the paper, and are as 
follows: 
 
MR:                 1.655       5.171 
logP                 -0.01         2.95 
LUMO           -1.159      -0.101 
  
 
Appropriate measures of goodness-of-fit, robustness and predictivity 
     
    The goodness-of-fit reported by the authors consists of the accuracy, sensitivity and specificity 
parameters (see above). Our re-analysis of the original data reproduced the reported QSAR equation 
and statistical parameters (including the LOO analysis). 
   Since the training set includes only 3 negatives, no meaningful LMO  cross-validation is possible.  
 
   The QSAR model was assessed by the authors for its predictivity in Ref. 61. Five untested 
chemicals were identified in commercial catalogues, and then tested experimentally in the same 
laboratory. The predictivity of the model on the external test set was:  
   External set, n = 5;     
   Percentage of chemicals correctly predicted  = 1.00.   
 
Characterization of the test set, in relation to the applicability domain of the training set 
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Structural domain: The basic structures of the test set chemicals were checked, and are within the 
range of the training set.  
 
 
Range of descriptors values of the test set: 
 
MR             2.580        6.910 
logP             0.59           3.49 
LUMO        -0.827       0.074 
 
 
Range of chemical similarity indices (PCs): 
                       Training set (N=20)  Test set (N=5) 
       Minimum         Maximum      Minimum         Maximum 
 Factor1  -0.976       1.524  -0.866       1.753 
 Factor2  -1.707       1.853   0.005        2.764 
 Factor3  -2.616       1.238  -2.508       1.717 
 
A mechanistic interpretation, if possible 
   The mutagenic activity in TA100 depends on the same factors (LUMO, MR, logP) that influence 
the mutagenic potency of active compounds (high electrophilicity, low steric hindrance and high 
lipophilicity favor the activity). This result is concordant with the scientific evidence on mechanism 
of action of these chemicals, which react as direct electrophiles to form adducts with DNA and 
proteins (the β- and carbonyl carbons are the points of attack). The partial charges on the carbonyl 
and β carbons, that are present in the equation for potency (QSAR 12), do not appear to influence 
the mutagenic activity.  
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3  Non-local (Q)SARs   
 
   To respond to the lack of individual QSARs for many chemical classes, a series of non-local 
models for noncongeneric sets of chemicals, i.e., general prediction models hopefully able to cope 
with the thousands of chemicals present in the environment, have been generated (Benigni 2005; 
Benigni & Richard 1998). Among those, a special place is held by the models based on Structural 
Alerts (SA). These were originally created as compilations of the scientific knowledge on the 
mechanisms of chemical carcinogenicity, without any use of statistics; more recently, refinements 
have been attempted with the support of more formal approaches (e.g., statistics / artificial 
intelligence). The knowledge on the action mechanisms as exemplified by the SAs is routinely used 
in SAR assessment in the regulatory context. In addition, the SAs are at the basis of popular 
commercial systems (e.g., DEREK).  
 
3.1 The short listed models            
   In the context of this evaluation, it should be noted that the SA-based models in Appendix 1 are 
potentially suited for in depth analyses, whereas other non-local models (listed in Appendix 1 as 
well) require the use of proprietary descriptors / algorithms (see also Appendix 2). Four SA models 
were identified as particularly promising, and were characterized in this study (Table I). They are 
very different in nature, ranging from completely non-formalized ones (expert knowledge, no use of 
statistics), to models formalized and implemented into computer software.   
   A first model is the compilation of SAs by John Ashby (Ref. 62) (see also (Ashby & Tennant 
1988)). The latter reference includes additional SAs in respect to the classical poly-carcinogen 
reproduced in Figure 4a (e.g., PAH), as well as some detoxifying chemical functionalities (e.g., 
sulfonic groups on azo-dyes, sterically hindering groups on the aromatic amino nitrogen). This 
model has a total of 19 SAs.  
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   The compilation of SAs by Bailey et al, (Ref. 65) was generated for being used in the regulatory 
context of the newly implemented Food and Contact Notification program of the U.S. Food and 
Drug Administration (FDA) Office for Food Additive Safety. The list of SAs is based on the 
Ashby’s SAs, and on a related list compiled by Munro (Munro, Ford, Kennepohl & Sprenger 1996). 
It consists of 33 SAs. 
    Kazius et al., 2005, (Ref. 63) produced another list of SAs (29 in total), based on a computerized 
data mining analysis whose results were “supervised” with an eye to the expert knowledge 
formalized by John Ashby. As noted above, the Ashby’s SAs are tailored on the mechanistic 
knowledge on chemical carcinogens, mainly restricted to the genotoxic (DNA reactive) 
carcinogens. The exercise by Kazius et al. 2005 used a mutagenicity database (4337 mutagens and 
nonmutagens from the Toxnet database http://toxnet.nlm.nih.gov/ ). Thus, the resulting SAs are 
typical of Salmonella mutagens, and for this reason they are rigorously restricted to the genotoxic 
carcinogens. 
    The fourth set of SAs was generated by Kazius et al 2006, (Ref. 64) in an exercise aimed at 
experimenting a new way of representing the chemicals (hierarchical graphs) and a new searching 
algorithm (called Gaston). The goal was to generate automatically SAs through artificial 
intelligence methods solely. This effort resulted in 6 “complex” SAs. 
 
3.2 Building the capacity to manipulate the SAs    
 
   In order to be able to properly assess the short listed models, it is necessary to have the capacity to 
manipulate the SAs: thus, for the present work we built in our laboratory the capacity to implement 
the SAs into computer programs. In practice, we coded the SAs into .mol files, and we managed 
them with the Leadscope software (Leadscope Inc, Columbus, OH; http://www.leadscope.com) that 
is  able to read Chemical Relational Databases and to perform substructure searching. Leadscope 
was used to manage the databases employed as probes as well. 
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   However simple in principle, the coding of the SAs presents a range of difficulties. First of all, the 
SAs are usually defined in a quite generic way by the authors, without the degree of precision 
required by the computer programs. Thus, it is necessary an effort to interpret the definitions, and 
then assess the influence of various, slightly different ways of coding the SAs by checking how they 
perform on selected databases of known toxic / nontoxic chemicals. In practice we wrote standard  
.mol files of the SAs, but subsequently we had to modify some of them manually. Moreover, some 
SAs actually consist of a range of co-existing substructures; such SAs are difficult to implement 
into one file, and (when necessary)  were replaced by sets of queries. An additional difficulty 
derives from the fact that different software programs have different idiosyncrasies, and the .mol 
files written for one program may be not appropriate for another program. The result is that an 
accurate coding of the SAs, taking into account both the intentions of the authors and the 
idiosyncrasies of the software programs, is quite a delicate and time consuming task. In spite of the 
above difficulties, we were able to code the four sets of  SAs mentioned above, and to check their 
performance. 
 
3.3 Probes for the SAs: the databases 
   The models selected were compared by checking their ability to identify mutagens and 
carcinogens in different databases. Three databases with general relevance were used as  probes. It 
should be remarked that the three databases contain chemicals with very diverse structures; a 
majority of them has been tested for mutagenicity and carcinogenicity  because of their 
environmental importance, however they also contain many pharmaceuticals tested for their effects 
on human health.  
   One is the database of Salmonella mutagenicity data collected by (Kazius, McGuire & Bursi 
2005) for their refinement of the Ashby’ SAs. It consists of 4337 mutagens and nonmutagens, that 
the authors retrieved mainly from the Toxnet public database (http://toxnet.nlm.nih.gov/).  
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   The other two databases include both rodent carcinogenicity and Salmonella mutagenicity data. 
One is the Carcinogenic Potency DataBase (CPDB) hosted at the DSSTox website 
(http://www.epa.gov/ncct/dsstox/index.html ) (n = 1189), and the other one is the ISSCAN database 
on animal carcinogens, hosted at the website of the Istituto Superiore di Sanita’ 
(http://www.iss.it/ampp/dati/cont.php?id=233&lang=1&tipo=7 ) (n = 890). The latter two 
databases are largely overlapping; however, there are some differences both in the chemicals 
included and in a number of mutagenicity and carcinogenicity calls (Benigni & Bossa 2006; 
Richard 2004) (Richard 2004) (Richard & Williams 2003). 
 
3.4 The characterization of the SAs-based models 
 
   Since two out four models were generated with no use of statistics at all, and the other two have 
not an algorithmic form, a systematic comparison according to the scheme adopted above for the 
QSARs  is not feasible. A narrative presentation of our analyses is adopted.  
    To display the results of each analysis, a Receiver Operating Characteristics (ROC) graph is used. 
It reports true positive rate (sensitivity) on the Y-axis, and false positive rate (1 - specificity) on the 
X-axis. In a ROC graph, perfect performance is located at the left upper corner; the diagonal line 
represents random results (Provost & Fawcett 2001). 
                             
3.4.1 Ashby’ SAs 
 
   Table III lists the Ashby’ SAs (Ref. 62). Figure 5 displays the result of the application of the 
Ashby’ SAs to the 3 databases. The figure indicates that the agreement between Ashby’ SAs, and 
mutagenicity and carcinogenicity respectively, is very similar for CPDB and ISSCAN. The 
agreement with the Toxnet mutagenicity data is slightly lower than that with the CPDB and 
ISSCAN mutagenicity data, but still a cluster of “mutagenicity predictions” is clearly apparent. In 
quantitative terms, the agreement (accuracy) between Ashby’s SAs and Salmonella mutagenicity 
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outcomes is 0.73 to 0.79, whereas the agreement with the rodent carcinogenicity outcomes is about 
10% lower, i.e., 0.62 to 0.65. 
 
Figure 5. The agreement between the Ashby’s SAs, and the mutagenicity and carcinogenicity calls 
in various databases is shown. (Circles: mutagenicity databases; Triangles: carcinogenicity 
databases). 
 
 There is wide evidence demonstrating that among the short-term mutagenicity assays, the Ames 
test has the highest correlation with, and predictive ability for rodent carcinogenicity (Benigni 1995; 
Zeiger, Haseman, Shelby, Margolin & Tennant 1990) (Zeiger 1994). Thus, the Ashby’s SAs and the 
Ames test were compared for their ability to predict the carcinogenicity data in the CPDB and 
ISSCAN databases. Figure 6 shows that the agreement between Ames test and rodent 
carcinogenicity is of the same order of magnitude of that between SAs and rodent carcinogenicity.  
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Table III:   Ashby’ Structural Alerts 
1. Alkyl esters of either phosphonic or sulphonic acids;  
2. Aromatic nitro groups;  
3. Aromatic azo groups;  
4. Aromatic rings N-oxides;  
5. Aromatic mono- and dialkylamino groups;  
6. Alkyl hydrazines;  
7. Alkyl aldehydes;  
8. N-methylol derivatives;  
9. Monolakenes;  
10. N and S, β-haloethyl;  
11. N-chloroamines;  
12. Propiolactones and propiosultones;  
13. Aromatic and aliphatic aziridinyl derivatives;  
14. Aromatic and aliphatic substituted primary alkyl halides;  
15. Derivatives of urethane (carbamates);  
16. Alkyl N-nitrosoamines;  
17. Aromatic amines (including their N-hydroxy derivatives and the derived esters);  
18. Aliphatic and aromatic epoxides; 
19. Polycyclic aromatic hydrocarbons. 
   
  It should be remarked that the pattern of relationships among animal (rodent carcinogenicity), in 
vitro (Salmonella) and theoretical (SAs) models displayed in Figure 6 is not trivial. It confirms, in 
quantitative terms, that the SAs and the Salmonella assay are two different representations of the 
same mechanistic knowledge on chemical carcinogenicity derived from the seminal work of the  
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Figure 6. Together with the information reported in Figure 4 (empty symbols), the ROC graph 
shows the agreement between the Salmonella mutagenicity results and rodent carcinogenicity in the 
CPDB and ISSCAN databases (filled rhombuses). 
 
Millers (Miller & Miller 1981a; Miller & Miller 1981b) (and subsequent investigations). Thus, they 
have a similar degree of correlation with rodent carcinogenicity. At the same time, even though 
stemming from chemical carcinogenicity mechanistic knowledge, the SAs agree with Salmonella 
data better than with carcinogenicity data. In fact, they represent the DNA reactive (genotoxic) 
mechanisms of carcinogenicity, which were the main subject of study of the Millers and which were 
also the basis for the construction of the Salmonella typhimurium strains used for the Ames test 
(Ames 1984). This explains the higher correlation of the SAs with Salmonella than with 
carcinogenicity.  
   Figure 6 also points to what is missing in the Ashby’ SAs to obtain a higher agreement with 
rodent carcinogenicity along the Sensitivity dimension (Y-axis in the ROC graphs): the knowledge 
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on nongenotoxic carcinogens. Regarding the limitations of the SAs in Specificity (X-axis), it can be 
hypothesized that the knowledge coded into the SAs is a poor representation of the Absorption, 
Distribution, Metabolism and Excretion (ADME) component. 
 
3.4.2 Bailey’ SAs  
 
   Table IV lists the Bailey’ SAs (Ref. 65); Figure 7 displays the agreement between this set of SAs, 
and the Salmonella and rodent carcinogenicity data. For a comparison, the Ashby’ SAs are also 
included. Whereas the two sets of SAs have similar sensitivity, they are different in terms of 
specificity. The Bailey et al. SAs give rise to more false positive responses in respect to Ashby’ 
SAs. This lower specificity may be explained with a more conservative approach taken in the 
regulatory context of the generation of the SAs list. In other terms, the Bailey’ SAs are a more 
conservative version of the Ashby’ SAs. 
 
Table IV: Bailey’ Structural Alerts 
1. Primary  and secondary aromatic amines (with methyl or ethyl, or activated  methyl or ethyl, 
substituents) 
2. Tertiary aromatic amines (with methyl or ethyl substituents) 
3. Secondary aromatic acetamides and formamides  
4. Nitroarenes  
5. Nitrosoarenes  
6. Arylhydroxylamines  
7. N-nitroso-N-dialkylamines  
8. N-nitroso-N-alkylamides  
9. N-nitroso-N-alkylureas  
10. N-nitroso-N-alkylcarbamates  
11. N-nitrosos-N-alkylnitriles  
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12. N-nitroso-N-hydroxylamines  
13. Hydrazines  
14. Azoxy alkane 
15. Aliphatic halides 
16. Benzylic halides  
17. Oxiranes and aziridines  
18. Propiolactones  
19. Alkyl esters of sulfonic and sulphuric  acids (with methyl or ethyl substituents) 
20. Alkyl esters of phosphonic and phosphoric acids (with methyl or ethyl substituents) 
21. Mixed alkyl esters of phosphoric with methyl or ethyl substituents) 
22. Haloethylamines  
23. Haloalkylethers (ethyl and methyl) 
24. α-Halocarbonyl or a-halohydroxy  
25. Haloamines  
26. α,β-unsaturated carbonyls (aldehyde, ketone, ester, or amide group) 
27. Allylic halides and alkoxides (Cl, Br or I) 
28. Halogenated methanes  
29. Vinyl halides (Cl, Br or I) 
30. Polycyclic aromatic hydrocarbons 
31. Isocyanate  
32. Isothiocyanate  
33. Azoarenes (sulfonic group on both rings non-alerting) 
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Figure 7.  The agreement between the Bailey’ SAs, and the mutagenicity and carcinogenicity calls 
in various databases is shown. For a comparison, also the performance of the Ashby’ SAs is shown. 
(Circles: mutagenicity databases; Triangles: carcinogenicity databases; 
Filled symbols: Bailey’ SAs; Empty symbols: Ashby’ SAs).  
 
 
3.4.3 Kazius et al., 2005, SAs 
 
   Table V lists the SAs derived by Kazius et al., 2005 (Ref. 63).  Figure 8 reports the application of 
this set of SAs to the probes. Overall, this set of  SAs did not perform much differently from 
Ashby’s SAs (a small increase in Sensitivity is balanced by a small decrease in Specificity). An 
expected result is that the Kazius 2005 SAs performed better than the Ashby’ SAs on the 
genotoxicity database (Toxnet), which was used as training set.  
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Table V:  Kazius’ Structural Alerts (2005) 
1. Specific aromatic nitro 
2. Specific aromatic amine 
3. Aromatic nitroso    
4. Alkyl nitrite       
5. Nitrosamine         
6. Epoxide             
7. Aziridine           
8. Azide               
9. Diazo               
10. Triazene            
11. Aromatic azo        
12. Unsubstituted heteroatom-bonded heteroatom 
13. Aromatic hydroxylamine                             
14. Aliphatic halide                            
15. Carboxylic acid halide                      
16. Nitrogen or sulfur mustard                  
17. Bay-region in polycyclic aromatic hydrocarbons     
18. K-region in polycyclic aromatic hydrocarbons        
19. Polycyclic aromatic system                          
20. Sulfonate-bonded carbon (alkyl alkane sulfonate or dialkyl sulfate)  
21. Aliphatic N-nitro  
22. α,β-unsaturated aldehyde (including R-carbonyl aldehyde)  
23. Diazonium  
24. β-propiolactone  
25. α,β-unsaturated alkoxy group  
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26. 1-aryl-2-monoalkyl hydrazine  
27. Aromatic methylamine  
28. Ester derivative of aromatic hydroxylamine  
29. Polycyclic planar system 
 
 
Figure 8.  The agreement between the Kazius’ SAs (first set), and the mutagenicity and 
carcinogenicity calls in various databases is shown. For a comparison, also the performance of the 
Ashby’ SAs is shown. 
(Circles: mutagenicity databases; Triangles: carcinogenicity databases; 
Filled symbols: Kazius’ SAs; Empty symbols: Ashby’ SAs).  
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3.4.4 Kazius et al., 2006, SAs 
 
    
   The fourth set of SAs (Table VI) considered was generated by Kazius et al., 2006, (Ref. 64) as an 
exercise of application of machine learning methods, and has to be judged within this perspective. 
Figure 9 shows that this set of SAs was inferior to the Ashby’s SAs as agreement with Salmonella 
data, whereas had a higher specificity but somewhat lower sensitivity for the carcinogens.  
 
 
 
Table VI:  Kazius’ Structural Alerts (2006) 
1. Highly branched substructure, composed by 11 planar atoms connected with planar bonds; 
2. Nitrogen atom connected through a double bond to a nitrogen or an oxygen atom; 
3. Aliphatic epoxides and aziridines; 
4. Aliphatic halogen (chlorine, bromine, and iodine); 
5. Aromatic primary amine; 
6. Heteroatom (N, O)-bonded heteroatom (NH, OH) substructure. 
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Figure 9. The agreement between the Kazius’ SAs (second set), and the mutagenicity and 
carcinogenicity calls in various databases is shown. For a comparison, also the performance of the 
Ashby’ SAs is shown. 
(Circles: mutagenicity databases; Triangles: carcinogenicity databases; 
Filled symbols: Kazius’ SAs; Empty symbols: Ashby’ SAs).  
 
3.4.5 Non-general databases as probes 
 
   Overall, the four sets of SAs are not remarkably different from each other in terms of agreement 
with Salmonella mutagenicity and rodent carcinogenicity. What is interesting is the fact that they all 
show a similar pattern of correlation with the two endpoints. In turn, Salmonella data demonstrated 
a relationship with carcinogenicity data similar to that of the SAs. 
   Figures 5 to 9 report an estimation of the “average” ability of different sets of SAs to identify 
mutagens / carcinogens in large sets of data, including the majority of the chemicals with 
environmental relevance tested so far. It is interesting to investigate also how this average value is 
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modulated when the SAs models are applied to subsets of chemicals selected according to very 
specific criteria. Here, two extreme cases have been investigated. The first one regards a group of 
congeneric chemicals (aromatic amines) and the second one regards a group of pharmaceuticals, 
with very diverse chemical structures. 
 
Figure 10.   The agreement between the Ashby’ and Kazius’ SAs (first (05) and second (06) set), 
and the mutagenicity and carcinogenicity calls in a database of aromatic amines is shown.   
(Circles: mutagenicity; Triangles: carcinogenicity). 
 
   
The aromatic amines are the chemical class with the largest amount of available experimental data. 
The mutagenicity and the carcinogenicity data used for this analysis were retrieved from the 
compilations of (Debnath, Debnath, Shusterman & Hansch 1992) and (Franke, Gruska, Giuliani & 
Benigni 2001). Figure 10 shows the application of different sets of SAs to the aromatic amines. 
Whereas the sensitivity is very high, the specificity is very low. The sensitivity is high for trivial 
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reasons, because all the chemicals contain at least one alert, i.e. an amino group. Regarding the 
specificity, it appears that no set of SAs is able to discriminate efficiently between the aromatic 
amines that are actually toxic, and those whose potential is not expressed in the experimental 
system. Thus, the application in Figure 10 indicates that the SAs considered are poorly suitable to 
express the gradation of effects that different molecular environments exert on the potentially DNA 
reactive moiety.  
 
Figure 11. The ROC graph displays the agreement between various sets of SAs and the rodent 
carcinogenicity calls in a database of pharmaceuticals. For a comparison, the predictions by a 
human expert (Romano Zito) (Benigni & Zito 2003) are reported. 
 
    A second comparison of SAs on a specially selected subset of chemicals was performed on a 
database of pharmaceuticals with carcinogenicity data (Figure 11). This dataset was previously used 
as test set in a Predictive Toxicology Challenge (PTC) on rodent carcinogenicity (Benigni & 
Giuliani 2003; Helma & Kramer 2003). In the PTC exercise, the carcinogenicity of the 
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pharmaceuticals test set was predicted with a range of machine learning algorithms, which had been 
previously trained on a set of industrial chemicals (training set). Overall, the result of the PTC 
exercise was quite deceiving, one advocated reason being that the training (industrial) and test 
(pharmaceutical) sets were structurally quite dissimilar.  
   Figure 11 supports the PTC conclusions. The sets of SAs performed quite poorly on the 
pharmaceuticals, mainly due to low sensitivity: many pharmaceutical carcinogens remained 
unnoticed because appropriate SAs are not available. Since many carcinogens in the 
pharmaceuticals set are negative in the mutagenicity assays, it can be assumed that they act through 
nongenotoxic mechanisms. This result stresses the need for developing lists of SAs for the 
nongenotoxic mechanisms of chemical carcinogenicity (Woo 2003). For the sake of comparison, 
Figure 11 reports the results of the prediction of the carcinogenicity of the PTC pharmaceuticals by 
a human expert (Romano Zito) (Benigni & Zito 2003). It appears that the human expert 
outperformed all the sets of SAs in sensitivity, thus indicating the existence of an additional body of 
knowledge that can be potentially transformed into formalized rules (e.g., SAs).   
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4 Conclusions  
 
   This evaluation of the non-commercial (Q)SARs for mutagenicity and carcinogenicity consisted 
of a preliminary survey (Phase I), and then of a more detailed analysis of short listed models (Phase 
II). In Phase I, the models were collected from the literature, and then assessed according to the 
OECD principles –based on the information provided by the authors-; thus Phase I provided the 
support for short listing a number of promising models (Table I), that were analyzed more in depth 
in Phase II. In Phase II, the information provided by the authors was completed and complemented 
with a series of analyses aimed at generating an overall profile of each of the short listed models. 
This included statistical analyses of the models, generation of external test sets for the assessment of 
external predictivity, generation of new models for activity.  Given their different natures, the 
assessment scheme for the QSAR models for congeneric sets of chemicals was different from that 
adopted for the global, or non-local models.     
 
 
4.1 QSARs for congeneric sets of chemicals 
    
   The literature contains QSARs for most of the top ranking classes of the EU HPV list (Table II), 
with the notable exception of the halogenated aliphatics. For this important chemical class only 
models for the genotoxic activity in Aspergillus nidulans (aneuploidy) exist (Refs. 51 and 52 in 
Appendix 1), but this assay has no regulatory recognition (thus, Refs. 51 and 52 were not included 
in Phase II of this work).  
   The congeneric QSARs almost exclusively aim at modeling Salmonella mutagenicity and rodent 
carcinogenicity, which are crucial toxicological endpoints in the regulatory context. However, the 
lack of models for in vivo genotoxicity should be remarked. According to an assessment carried out 
by the European Chemicals Bureau (ECB), the in vivo mutagenicity studies, shortly followed by 
carcinogenicity, are posing the highest demand for test-related recourses (Pedersen, de Brujin, 
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Munn & Van Leeuwen 2003; Van der Jagt, Munn, Torslov & de Brujin 2004). In particular, the in 
vivo micronucleus test is widely used for regulatory purposes as follow-up to bacterial 
mutagenicity, and requires the sacrifice of large numbers of animals. A QSAR alternative is 
desirable.     
   Many available QSARs model the potency of active chemicals (mutagens or carcinogens) only. 
However, it is recognized that in the field of mutagenicity and carcinogenicity the difference 
between actives and inactives, and the gradation of potency of the actives may depend on different 
chemical properties, so they should be modeled separately (Benigni, Andreoli & Giuliani 1994; 
Franke, Gruska, Giuliani & Benigni 2001). When possible (i.e., mutagenic activity of aromatic 
amines in two Salmonella strains), we filled the gaps by generating new models specifically for this 
project (QSAR5 and QSAR6).      
   Overall the short listed models -either reported by other authors or generated by us- can be 
interpreted mechanistically, and they agree with, and/or support the available scientific knowledge.   
   Regarding statistics (e.g., fitting parameters, cross-validation, etc...), the data provided by the 
authors together with the measures calculated by us pointed out that –overall- the short listed 
models are of good quality (except maybe some low values in cross-validation for QSAR3, 
QSAR12, and QSAR13. However, this did not influence the ability of predicting external test sets –
see below-).  
   A crucial point is that of  “validation”. Whereas it is generally accepted that the gold standard is to 
test the model on a set of chemicals not used for the derivation of the model, in practice many 
investigators use different statistical procedures to generate artificial test sets (e.g., by splitting the 
sample of chemicals into two sets, and regarding one as training and the other one as test set).  
However, it is our opinion that all these internal validation procedures only generate different 
statistical descriptions of the same original data subjected to modeling. A crucial and necessary 
further assessment is to subject the model to a real external validation test: the activity of  
congeneric chemicals -not considered in any way at the moment of the generation of the model- are 
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predicted, and the predicted and experimental activities are compared. Thus, we searched the 
literature for external data sets not considered by the authors of the models, and whenever the data 
were available, we performed external prediction exercises (for QSAR1 to QSAR10. It has not been 
possible for QSAR11, whereas for QSAR13 the external predictivity was assessed by the authors).  
   In the selection of the external sets, the constraint for a test set to belong to the Applicability 
Domain of the training set was taken into account by considering: a) the types of structures to which 
the model applies. This was assessed subjectively by us according to our expert knowledge, by 
checking, among others, the absence of reactive groups different from those that characterize the 
chemical class under study; b) the ranges of descriptors values of the two sets; c) a mathematical 
transform of structural similarity indices (ranges of PC scores). Criterion a) was considered crucial, 
and Criteria b) and c) were considered as confirmatory. A preliminary assessment showed that the 
external test sets used by us were by and large within the applicability domains of the models (i.e., 
training sets), and that minor deviations did not affect the goodness of prediction. For example, in 
QSAR1 there is only one chemical in the test set that has a logP value outside the range of the 
training set, but for all the other parameters (HOMO, LUMO, and similarity indices) the training 
and test sets overlap. 
   The results of the external prediction tests are reported in the individual sections. These results, 
viewed together with the various statistical measures on the training sets, provide very interesting 
evidence. The following is the description of our results.   
    Table VII summarizes the external prediction outcomes for regression based models (i.e., QSAR 
models for potency), and Table IX summarizes the outcomes for discriminating models (i.e., QSAR 
models for activity). The two tables report also parameters for goodness of fit and different internal 
validations of the training set. In addition, Table VIII shows the correlation coefficients among the 
parameters in Table VII, and Table X shows the correlation coefficients those in Table IX.   
   Inspection of Table VII indicates that the goodness of fit in the training set (correlation 
coefficient, rtra) is always considerably better than the goodness of prediction (rte) for the test set. 
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rte is the correlation coefficient between predicted and experimental potency of the test set. It also 
appears that the internal validation measures (q2 and q2_10) are lower than the back-fitting of the 
model (rtra), but still considerably higher than the external prediction rte.  This suggests that the 
internal validation measures are bad predictors of the performance with external test sets. 
    
 
Table VII : Regression-based models for Potency: fit and predictivity measures    
 
QSAR      System     rtra q2 q2_10 lever  rte accte  
 
qsar1     TA98      .90       .78 .71 .06  .41 .36  
qsar2     TA100      .88       .74 .66 .06  .68 .57  
qsar3     mouse      .91       .58 .0 .25  .56 .58  
qsar4     rat        .93       .81 .79 .15  .48 .71 
qsar9     TA98       .90       .89 .80 .04       -.23 .43  
qsar10    TA100      .88       .77 .73 .05  .36 .32  
 
 
   An alternative way of measuring the prediction performance for regression based models is to 
calculate its accuracy as percentage of test chemicals correctly predicted within one log unit of 
activity (accte). When expressed as accte, the prediction performance is a more robut estimate than 
when expressed as rte (see for example QSAR9, which shows a negative correlation between 
predicted and experimental potency values (rte), whereas the percentage of chemicals correctly 
predicted within one log unit (accte) is 0.43). This is understandable, since high  rte values require 
exact point estimates, whereas high accte requires correct estimates of intervals; the latter is a less 
stringent criteria and, in addition, is closer to the regulatory needs. Overall, the QSAR external 
predictions for the potency of congeneric chemicals are 30 to 70 % correct (as seen as accte).   
   Table VIII indicates that rtra is correlated with accte but not with rte, thus indirectly confirming 
that accte is a performance index more robust than rte.  
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    Regarding the internal validation indices q2, q2_10 and mean Leverage (lever), Table VIII shows 
that q2 and q2_10 (Leave-10%-Out crossvalidation) are negatively correlated with both rte and 
accte. In addition the mean Leverage (lever), whose high values are supposed to indicate “bad” 
models with uneven influence of individual data points on the models themselves, are positively 
correlated with both the external validation indices rte and accte. All these results are contrary to 
what one could expect.  
 
Table VIII:  Regression-based models for Potency: Correlation Coefficients 
 
               rtra  q2  q2_10  lever    rte  accte 
  rtra           1.00  0.09  -0.02  0.52       -0.07   0.60 
  q2              1.00     0.93  -0.77       -0.69  -0.25 
  q2_10           1.00  -0.84       -0.39  -0.25 
  lever             1.00        0.43  0.62 
  rte              1.00  0.41 
  accte              1.00 
                  
 
 
   The results of external validation for the discriminant models (activity)  are in Table IX. As in the 
case of regression based models, the overall accuracy in the training set (acctra) is systematically 
higher than that attained in the external test set (accte). However, the external prediction 
performance is 63 to 100 % accurate, considerably higher than that of the regression models for 
potency (30 to 70 %). This confirms the evidence that predicting intervals is more reliable than 
predicting individual data points.   
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Table IX:  Discriminant models for Activity: fit and predictivity measures    
 
QSAR    System  sqcc acctra acc10  accte  
 
qsar7    rodent 0.38 0.88 0.75  0.67  
qsar8    rodent 0.50 0.94 0.78  0.70  
qsar5    TA98 0.31 0.83 0.83  0.63  
qsar6      TA100  0.39 0.79 0.65  0.69  
qsar13    TA100 0.61 1.0 0.85  1.0  
 
 
 
    More information is reported in Table X, which shows that the accuracy in the training set 
(acctra) is a good predictor of external predictivity (accte). An even better predictor of external 
predictivity is the Squared Canonical Correlation (sqcc) of the model.  
   Table X also shows that, as in the case of regression based models, the internal validation index  
(here acc10: cross-validation Leave-10%-Out) is a mediocre indicator of external predictivity.  
 
Table X: Discriminant models for Activity: correlation coefficients 
 
                                 sqcc        acctra         acc10          accte 
                 sqcc         1.00       0.89             0.37         0.90 
                 acctra               1.00             0.68         0.78 
                 acc10                         1.00         0.45 
                 accte              1.00 
 
 
   Whereas generally the importance of crossvalidation is overestimated in the QSAR literature, a 
few authors have pointed to the limitations of crossvalidation as an assessment of the “goodness” of 
a model (e.g., (Golbraikh & Tropsha 2002) (Kubinyi 2005)). This report, based on a number of real 
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case studies and not only on computer simulations, adds new supporting evidence, and expands the 
reach of the previous observations on the limits of internal validation. Thus, complementary roles 
can be envisaged for internal and external validation procedures. The internal validation procedures 
are useful tools in the phase of the model construction (statistical consistency), whereas external 
validation assesses the confidence one can have in the predictions of the model itself.        
 
4.2 SARs for non-congeneric data sets 
 
   Among the non-local, or global approaches for non-congeneric data sets, four models based on 
the use of Structural Alerts (SA) were short listed and investigated in more depth (Table I). These 
models were selected because of the overriding importance of the SAs as a basis for evaluations by 
human experts in the regulatory context, and for implementations into computer programs. In order 
to assess the four sets, it was necessary to preliminarily build in our laboratory the capacity to 
implement the four sets into one computer platform: this allowed us to compare in a systematic way 
the four sets on the same probes (i.e., databases of mutagens and carcinogens).         
   Overall, the four sets did not differ to a large extent in their performance. In the “general” 
databases the SAs appear to agree around 65% with rodent carcinogenicity data,  and 75% with 
Salmonella mutagenicity data. These figures can be considered as “general” measures of the 
predictive ability of the SAs for the “known“ universe of chemicals associated with experimental 
data (which is not the entire universe of all possible chemicals).  
   On the other hand, SAs based models do not seem to work equally efficiently in the 
discrimination between active and inactive chemicals within individual chemical classes  (see the 
exercise on the class of the aromatic amines). This because of the lack of detailed sub-rules 
describing how each alert is modulated by the different molecular environments. This kind of more 
refined modeling is the purpose of the QSARs for individual chemical classes (which, however, 
exist only for a limited number of them). 
 93
   It should be remarked that the evolving societal have a strong influence on the database of 
“important” chemicals and, consequently, on the predictive ability of the SAs. Table XI  shows the 
distribution of the SAs (our unpublished results) among a set of chemicals bioassayed by the US 
National Toxicology Program (NTP) in the recent years (http://ntp.niehs.nih.gov/). It appears that 
only a few of them have recognizable SAs, and that several rodent carcinogens do not posses SAs at 
all. For example, Ashby’ SAs are in 3 out 25 carcinogens, and Bailey’ SAs are in 6 out 25 
carcinogens.  In addition, several carcinogens are non-mutagenic (only 8 out 22 carcinogens are 
Salmonella mutagens):  hence, they are putatively nongenotoxic. The progressive decline of the 
proportion of genotoxic carcinogens during the years is a positive effect of the increased knowledge 
on the genotoxic mechanisms of carcinogenesis; this has permitted a reduction of the number of 
new chemicals with known SAs that have been put into the market. However, this temporal trend 
also diminishes our ability to recognize carcinogens through the established lists of SAs, and sets up 
a different scenario to be faced by predictive systems. In this new scenario, the need of formulating 
models for nongenotoxic carcinogens is a priority.  
   In addition to the above area, there are two more areas where the expansion of the SAs is 
desirable. First, the lack of SAs specific for in vivo mutagenicity assays, e.g., micronucleus, that 
rely on the sacrifice of considerable numbers of animals, should be remarked. In fact, it is known 
that the classical genotoxicity assays (e.g., Salmonella) are not overlapping –in terms of endpoint 
and of chemicals to which are sensitive- with the in vivo assays (Benigni 1995).  Thus, this area 
deserves more research.  
   Second, our practical experience with the implementation of the SAs has indicated that also here 
there is space for further technical improvement. Beside the scientific principles, we think that a 
systematic effort to combine the best of the various sets of SAs and to expand the sub-rules is 
necessary.   
    
 
 94
 
NTP ChemName CAS Ashby Bailey Kazius05 Kazius06 Canc Sty 
TR500 Naphtalene 91-20-3 no no no no + - 
TR501 4,4[-Dichlorodiphenyl sulphone] 80-07-9 no no no no - - 
TR502/503 Chloral Hydrate 302-17-0 no no yes yes + + 
TR504 o-Nitrotoluene 88-72-2 yes yes yes yes + - 
TR505 Citral 5392-40-5 yes yes N.A. N.A. ? - 
TR506  Acrylonitrile 107-13-1 no no N.A. N.A. + + 
TR507  Vanadium Pentoxide 1314-62-1 no no no no + - 
TR508 Riddelliine 23246-96-0 no yes no no + + 
TR509 2,4-Hexadienal  142-83-6 yes yes N.A. N.A. + + 
TR511 Dipropylene Glycol  25265-71-8 no no N.A. N.A. - - 
TR512 Elmiron 37319-17-8 no no yes no + - 
TR513 Decalin 91-17-8 no no N.A. N.A. + - 
TR514  trans-Cinnamaldehyde 14371-10-9 yes yes N.A. N.A. - - 
TR515 Propylene Glycol Mono-t-Butyl Ether 57018-52-7 no no no no + + 
TR516  2-Methylimidazole 693-98-1 no no N.A. N.A. + - 
TR517 Sodium Chlorate  7775-09-9 no no no no + - 
TR518 Triethanolamine  102-71-6 no no N.A. N.A. + - 
TR520  3,3',4,4',5-Pentachlorobiphenyl (PCB 126)  57465-28-8 no no no no + N.D.
TR521 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) 1746-01-6 no no N.A. N.A. + - 
TR522  Transplacental AZT 30516-87-1 no yes N.A. N.A. + + 
TR523 Diisopropylcarbodiimide  693-13-0 no no N.A. N.A. - - 
TR525 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) 57117-31-4 no no yes yes + N.D.
TR527a Malachite Green Chloride 569-64-2 yes yes no no ? + 
TR527b Leucomalachite Green  129-73-7 yes yes N.A. N.A. ? - 
TR529 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153) 35065-27-1 no no no no ? N.D.
TR532 Bromodichloromethane 75-27-4 no no yes yes + - 
TR533 Benzophenone  119-61-9 no no N.A. N.A. + - 
TR534 Divinylbenzene-HP  1321-74-0 no no N.A. N.A. ? - 
TR535 4-Methylimidazole 822-36-6 no no no no + - 
TR537  Dibromoacetic Acid 631-64-1 no no N.A. N.A. + + 
TR538 Methyl Isobutyl Ketone  108-10-1 no no N.A. N.A. + - 
TR540 Methylene Blue Trihydrate 7220-79-3 yes yes N.A. N.A. + + 
TR543 α-Methylstyrene  98-83-9 no no N.A. N.A. + - 
TR545 Genistein 446-72-0 no yes no no + N.D.
 
Table XI. Agreement between four sets of SAs and carcinogenicity and mutagenicity calls in the 
chemicals most recently bioassayed by the US National Toxicology Program. The chemicals are 
identified by the Technical Report (TR) number, chemical name and CAS number. Yes / no indicates 
the presence of SAs (according to the different lists). N.A. (=Not Applicable) indicates that the 
chemical is in the training set of the model, thus the prediction is not considered. N.D. = No Data. 
+, -, ? indicates positive, negative, equivocal response to the carcinogenicity (Canc) and 
Salmonella mutagenicity (Sty) assays.   
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   A final comment on the issue of Applicability Domain is necessary. We did not attempt to define 
the AD of the four sets of SAs in the same systematic way as we did for the QSARs. Rigorously 
speaking, the AD of a certain SA is only the set of chemicals that contain that SA. An alternative 
 (practical) approach is to consider as AD of a set of SAs, the chemicals (or some representation of  
them) that were used to derive that set of SAs. But in many cases such a set of chemicals cannot be 
defined, e.g., for the Ashby’ or Bailey SAs, that originate from a complex body of mechanistic 
knowledge with different origins. To make things more contradictory, when we tested the four sets 
of SAs on a database of pharmaceuticals (the PTC chemicals) we measured the similarity 
(Tanimoto coefficients) of the PTC chemicals in respect to the chemicals in “general” databases 
(e.g., ISSCAN or CPDB). In that case, we found that the PTC chemicals were not different from 
some clusters of ISSCAN/CPDB chemicals (results not shown). Inspite of this similarity, the 
prediction ability of the SAs was very different in the general databases and in the PTC chemicals 
(see, for example Fig. 5 versus Fig. 11). Even though it can be argued that the adoption of different 
similarity measures may generate different similarity patterns, our previous research has shown that 
the similarity measure used may be critical at the small scale of congeneric chemicals, but for large 
and diverse data sets this choice usually has minor consequences on the resulting similarity values 
(Benigni, Gallo, Giorgi & Giuliani 1999). Overall, our opinion is that more research is still needed 
on the subject of the definition of AD issue for SAs.        
 
4.3 Final considerations 
      
   A general indication of this study, valid for both congeneric and noncongeneric models, is that 
there is uncertainty associated with (Q)SARs. Thus a prediction cannot be taken at face value, and 
the level of uncertaintly has to be considered when using (Q)SAR in a regulatory context. However, 
(Q)SARs are not meant to be black-box machines for predictions, but have a much larger reach and 
scope. Here applies the same reflection made by Rainer Franke regarding the search for new drugs: 
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“As the drug discovery process is of a very complex nature, effective drug design requires an entire 
spectrum of techniques in which QSAR methods still play an important role. … The real power of 
drug design methods is to extract and synthesize information from data to obtain hypotheses that 
can be put to experimental test. No dramatic overnight discoveries of wonder drug will result, but 
an increase in the chance of success due to indications of promising directions is a realistic 
expectation….” (Franke & Gruska 2003). Equally, a regulatory process often consists of a complex 
assessment that requires the combination of different types of evidence, among which there are 
(Q)SARs. Using only non-testing methods, the larger the evidence from QSARs (several different 
models, if available) and other approaches (e.g. chemical categories, read across) the higher the 
confidence in the prediction. 
   Regarding the SAs, their main role is that of preliminary, or large-scale screenings. This has been 
brilliantly demonstrated by the selection process for chemicals to be bio-assayed by the US National 
Toxicology Program. Two thirds of the chemicals selected for the bioassay were “suspect” 
chemicals: this selection was operated by human experts largely based on the recognition of SAs. 
Another one third was selected only on production/exposure considerations. As a matter of fact, the 
proportion of carcinogens among the “suspected” chemicals was almost ten times higher than that 
relative to the chemicals selected only on production/exposure considerations (Fung, Barrett & Huff 
1995). Thus, the recognition of SAs was a powerful tool to enrich considerably the target of the 
priority setting. It can be anticipated that a similarly successful role can be played by the SAs to 
support the process of grouping chemicals for read-across and category formation. 
   In comparison with the SAs and qualitative SARs, the QSARs for individual chemical classes –
when available- can be used with higher confidence. Evidence produced in this work has indicated 
that predictions of intervals (e.g., negative / positive) are more reliable than predictions of exact 
data points (e.g., potency).    
   Another general indication of this study is that a better balance between statistics on one side, and 
mechanistic knowledge and (Q)SAR know how on the other side is needed. As a matter of fact, one 
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result of our analysis on the QSARs for congeneric sets shows that some of the commonly accepted 
measures of internal validation (often generalized as “validation” tout court) is that they are very 
poor predictors of the ability of models to perform well with external data sets. Deriving and 
evaluating (Q)SAR models should not only rest on statistical criteria but should also properly take 
into account mechanistic aspects. This is crucial, since mechanistic interpretation is a very powerful 
tool for deciding about the validity of a (Q)SAR. In addition, it provides a ground for interaction 
and dialogue between model developers, and toxicologists and regulators, and permits the 
integration of the (Q)SAR results into a wider regulatory framework, where different types of 
evidence and data concur or complement each other as a basis for making decisions and taking 
actions.  
   An example can clarify further the advantages of the practice of using mechanistic (Q)SAR in the  
regulatory process. For example, recognizing that a certain chemical contains a SA will suggest to 
the regulator a possible mechanism of action. In addition, a QSAR (e.g., QSAR5, for identifying the 
mutagenic aromatic amines) will indicate also if the chemical is below or above a given reactivity 
threshold, and if the potential reactivity center is sterically hindered or the metabolic system has 
free access to it. Thus the information provided by (Q)SARs, even in the presence of the inherent  
uncertainty linked to the (Q)SARs themselves, will expand the knowledge on the chemical and will 
help the regulator to put into context other available evidence. 
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6 Scheme 1: OECD PRINCIPLES-BASED SCORING SYSTEM FOR THE (Q)SAR 
MODELS  
 
Defined end-point of regulatory importance:  the non-relevant models were eliminated in the 
preliminary phase (see text); no scores were given; 
 
A)  Unambiguous algorithm:  
A1)  statistical / mathematical procedure clearly described, reproducible based on the 
information provided; 
A2)  full details of the training set (A2.1: chemical identity; A2.2: biological data; A2.3:  
parameters values); 
A3)  easy access to parameters calculation; 
Scores: 
A1)  yes = 1;  no = 2; 
A2.1, A2.2, A2.3)  )  yes = 1;  no = 2;  
A3)  wide availability and acceptance of chemical descriptors  =  1; 
         limited availability of  chemical descriptors  =  2; 
         descriptors calculated by only one commercial program  =  3; 
         in-house descriptors =  4;   
 
B) Defined domain of applicability (descriptor space, structure space) 
Scores: 
descriptor AND  structure spaces defined  =  1; 
 descriptor OR  structure spaces defined  = 2; 
 none = 3; 
 
C)  Measures of  
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C1)  goodness-of-fit (e.g., r); 
C2)  robustness (e.g., q 2, leverage, separation into training/test set);  
C3)  predictivity (external data prediction); 
Scores: 
C1, C2, C3)   yes = 1;  no = 2; 
 
D)  Mechanistic interpretation 
Scores: 
Direct, possible = 1;  difficult = 2; 
 
E)  Others 
E1)  number of data points 
E2)  chemical class representation (number)  in the EU HPV chemicals.  
 
N.A. = Not Applicable.    
 
 
 104
7 Appendix 1 List of reviewed papers 
 
1. QSARs for congeneric series 
 
1.1 Aromatic amines 
 
1.1.1 Mutagenic activity 
 
 (1)  Trieff NM, Biagi GL, Sadagopa Ramanujam VM, Connor TH, Cantelli-Forti G, Guerra MC, 
Bunce III H, Legator MS. Aromatic amines and acetamides in Salmonella typhimurium TA98 
and TA100: A QSAR study. Mol Toxicol 1989; 2:53-65. 
 (2)  Ford GP, Griffin GR. Relative stabilities of nitrenium ions derived from heterocyclic amine 
food carcinogens: relations to mutagenicity. Chem Biol Interact 1992; 81:19-33. 
 (3)  Ford GP, Herman PS. Relative stabilities of nitrenium ions derived from polycyclic aromatic 
amines. Relationship to mutagenicity. Chem Biol Interact 1992; 81:1-18. 
 (4)  Debnath AK, Debnath G, Shusterman AJ, Hansch C. A QSAR investigation of the role of 
hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and 
heteroaromatic amines in Salmonella typhimurium TA98 and TA100. Environ Mol Mutagen 
1992; 19:37-52. 
 (5)  Benigni R. QSARs for mutagenicity and carcinogenicity. In: Anonymous, editor. Report from 
the Expert Group on (Quantitative) Structure-Activity Relationships ((Q)SARs) on the 
principles for the validation of (Q)SARs. Paris: OECD, 2004: 84-112. 
 (6)  Basak SC, Grunwald GD. Predicting mutagenicity of chemicals using topological and 
quantum chemical parameters: a similarity based study. Chemosphere 1995; 31:2529-2546. 
 (7)  Basak SC, Gute BD, Grunwald GD. Assessment of the mutagenicity of aromatic amines from 
theoretical structural parameters: a hierarchical approach. SAR QSAR Environ Res 1999; 
10:117-129. 
 (8)  Maran U, Karelson M, Katritzky AR. A comprehensive QSAR treatment of the genotoxicity 
of heteroaromatic and aromatic amines. Quant Struct -Act Relat 1999; 18:3-10. 
 (9)  Basak SC, Mills D. Prediction of mutagenicity utilizing a hierarchical QSAR approach. SAR 
QSAR Environ Res 2001; 12:481-496. 
(10)  Gramatica P, Consonni V, Pavan M. Prediction of aromatic amines mutagenicity from 
theoretical molecular descriptors. SAR QSAR Environ Res 2003; 14:237-250. 
(11)  Mattioni BE, Kauffman GW, Jurs PC, Custer LL, Durham SK, Pearl GM. Predicting the 
genotoxicity of secondary and aromatic amines using data subsetting to generate a model 
ensemble. J Chem Inf Comp Sci 2003; 43:949-963. 
(12)  Vracko M, Mills D, Basak SC. Structure-mutagenicity modelling using counter propagation 
neural networks. Environ Toxicol Pharmacol 2004; 16:25-36. 
(13)  Cash GG. Prediction of the genotoxicity of aromatic and heteroaromatic amines using 
electrotopological state indices. Mutat Res 2001; 491:31-37. 
 105
(14)  Cash GG, Anderson B, Mayo K, Bogaczyk S, Tunkel J. Predicting genotoxicity of aromatic 
and heteroaromatic amines using electrotopological state indices. Mutat Res 2005; 585:170-
183. 
(15)  Lewis DFV, Ioannides C, Walker R, Parke DV. Quantitative structure-activity relationships 
and COMPACT analysis of a series of food mutagens. Food Additives & Contaminants 1995; 
12:715-723. 
(16)  Benigni R, Andreoli C, Giuliani A. QSAR models for both mutagenic potency and activity: 
application to nitroarenes and aromatic amines. Environ Mol Mutagen 1994; 24:208-219. 
(17)  Hatch FT, Knize MG, Felton JS. Quantitative structure-activity relationships of heterocyclic 
amine mutagens formed during the cooking of food. Environ Mol Mutagen 1991; 17:4-19. 
(18)  Hatch FT, Colvin ME, Seidl ET. Structural and quantum chemical factors affecting mutagenic 
potency of aminoimidazo-azaarenes. Environ Mol Mutagen 1996; 27:314-330. 
(19)  Hatch FT, Colvin ME. Quantitative structure-activity (QSAR) relationships of mutagenic 
aromatic and heterocyclic amines. Mutat Res 1997; 376(1-2):87-96. 
(20)  Felton JS, Knize MG, Hatch FT, Tanga MJ, Colvin ME. Heterocyclic amine formation and 
the impact of structure on their mutagenicity. Cancer Letts 1999; 143:127-134. 
(21)  Hatch FT, Knize MG, Colvin ME. Extended quantitative structure-activity relationships for 80 
aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting 
mutagenic potency. Environ Mol Mutagen 2001; 38:268-291. 
 
1.1.2  Carcinogenic activity 
(22)  Loew GH, Poulsen M, Kirkjian E, Ferrel J, Sudhindra BS, Rebagliati M. Computer-assisted 
mechanistic structure-activity: application to diverse classes of chemical carcinogens. Environ 
Health Perspect 1985; 61:69-96. 
(23)  Benigni R, Giuliani A, Franke R, Gruska A. Quantitative structure-activity relationships of 
mutagenic and carcinogenic aromatic amines. Chem Revs 2000; 100:3697-3714. 
(24)  Franke R, Gruska A, Giuliani A, Benigni R. Prediction of rodent carcinogenicity of aromatic 
amines: a quantitative structure-activity relationships model. Carcinogenesis 2001; 22:1561-
1571. 
(25)  Vracko M. A study of structure-carcinogenic potency relationship with artificial neural 
networks. The using of descriptors related to geometrical and electronic structures. J Chem Inf 
Comput Sci 1997; 37:1037-1043. 
(26)  Gini G, Lorenzini M, Benfenati E, Grasso P, Bruschi M. Predictive carcinogenicity: a model 
for aromatic compounds, with nitrogen-containing substituents, based on molecular 
descriptors using an artificial neural network. J Chem Inf Comput Sci 1999; 39:1076-1080. 
 
1.2  Aromatic Nitrocompounds  
 106
1.2.1  Nitroarenes 
(27)  Biagi LG, Hrelia P, Gerra MG, Paolini M, Barbaro AM, Cantelli-Forti G. Structure-activity 
relationships of nitroimidazo (2,1-b) thiazoles in the salmonella mutagenicity assay. Arch 
Toxicol 1986; suppl.9:425-429. 
(28)  Walsh DB, Claxton LD. Computer-assisted structure-activity relationships of nitrogenous 
cyclic compounds tested in Salmonella assays for mutagenicity. Mutat Res 1987; 182:55-64. 
(29)  Maynard AT, Pedersen LG, Posner HS, Mckinney JD. An Ab initio study of the relationship 
between nitroarene mutagenicity and electron affinity. Mol Pharmacol 1986; 29(6):629-636. 
(30)  Compadre RL, Shusterman AJ, Hansch C. The role of hydrophobicity in the Ames test. The 
correlation of the mutagenicity of nitropolycyclic hydrocarbons with partition coefficients and 
molecular orbital indices. Int J Quantum Chem 1988; 34:91-101. 
(31)  Lopez de Compadre RL, Debnath AK, Shusterman AJ, Hansch C. LUMO Energies and 
hidrophobicity as determinants of mutagenicity by nitroaromatic compounds in Salmonella 
typhimurium. Environ Mol Mutagen 1990; 15:44-55. 
(32)  Debnath AK, de Compadre RLL, Debnath G, Shusterman A, Hansch C. Structure-activity 
relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with 
molecular orbital energies and hydrophobicity. J Med Chem 1991; 34:786-797. 
(33)  Debnath AK, Lopez de Compadre RL, Shusterman AJ, Hansch C. Quantitative Structure-
Activity Relationship investigation of the role of hydrophobicity in regulating mutagenicity in 
the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella 
typhimurium TA100. Environ Mol Mutagen 1992; 19:53-70. 
(34)  King RD, Muggleton SH, Srinivasan A, Sternberg MJE. Structure-activity relationships 
derived by machine learning: the use of atoms and their bond connectivities to predict 
mutagenicity by inductive logic programming. Proc Natl Acad Scie 1996; 93(1):438-442. 
(35)  Debnath AK, Hansch C. Structure-activity relationship of genotoxic polycyclic aromatic nitro 
compounds: further evidence for the importance of hydrophobicity and molecular orbital 
energies in genetic toxicity. Environ Mol Mutagen 1992; 20:140-144. 
(36)  Debnath AK, Hansch C, Kim KH, Martin YC. Mechanistic interpretation of the genotoxicity 
of nitrofurans (antibacterial agents) using quantitative structure-activity relationships (QSAR) 
and comparative molecular field analysis (CoMFA). J Med Chem 1993; 36:1009-1116. 
(37)  Caliendo G, Fattorusso C, Greco G, Novellino E, Perissutti E, Santagada V. Shape-dependent 
effects in a series of aromatic nitro compounds acting as mutagenic agents on S. typhimurium 
TA98. SAR QSAR Environ Res 1995; 4:21-27. 
(38)  Fan M, Byrd C, Compadre CM, Compadre RL. Comparison of CoMFA models for 
Salmonella typhimurium TA98, TA100, TA98+S9 and TA100+S9 mutagenicity of 
nitroaromatics. SAR QSAR Environ Res 1998; 9:187. 
(39)  Compadre RL, Byrd C, Compadre CM. Comparative QSAR and 3-D-QSAR analysis of the 
mutagenicity of nitroaromatic compounds. In: Devillers J, editor. Comparative QSAR. 
London: Taylor and Francis, Ltd, 1998: 111-136. 
 107
1.2.2  N-nitroso compounds  
(40)  Singer GM, Andrews AW, Guo S. Quantitative structure-activity relationships of the 
mutagenicity of substituted n-nitroso-N- benzylmethylamines: possible implications for 
carcinogenicity. J Med Chem 1986; 29:40-44. 
(41)  Hansch C, Leo A. QSAR of mutagenesis, carcinogenesis and antitumor drugs. 9-2-3. 
Nitrosoamines. Exploring QSAR. Fundamentals and applications in chemistry and biology. 
Washington, D.C.: American Chemical Society, 1995: 356-357. 
(42)  Dunn III WJ, Wold S. An assessment of carcinogenicity of N-nitroso compounds by the 
SIMCA method of pattern recognition. J Chem Inf Comput Sci 1981; 21:8-13. 
(43)  Frecer V, Miertus S. Theoretical QSAR study on carcinogenic potency of N-nitrosamines. 
Neoplasma 1988; 35:525-538. 
  
1.3  Quinolines 
(44)  Debnath AK, de Compadre RLL, Hansch C. Mutagenicity of quinolines in Salmonella 
typhimurium TA100, a QSAR study based on hydrophobicity and molecular orbital 
determinants. Mutat Res 1992; 280:55-65. 
(45)  Smith CJ, Hansch C, Morton MJ. QSAR treatment of multiple toxicities: the mutagenicity and 
cytotoxicity of quinolines. Mutat Res 1997; 379:167-175. 
  
1.4  Triazenes 
(46)  Shusterman AJ, Debnath AK, Hansch C, Horn GW, Fronczek FR, Greene AC, Watkins SF. 
Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test. The role of 
hydrophobicity and electronic effects. Mol Pharmacol 1989; 12:939-944. 
  
1.5  Polycyclic aromatic hydrocarbons 
(47)  Zhang L, Sannes K, Shusterman AJ, Hansch C. The structure-activity relationships of skin 
carcinogenicity of aromatic hydrocarbons and heterocycles. Chem Biol Interact 1992; 81:149-
180. 
(48)  Gallegos A, Robert D, Girones X, Carbo-Dorca R. Structure-toxicity relationships of 
polycyclic aromatic hydrocarbons using molecular quantum similarity. J Comput -Aided Mol 
Design 2001; 15:67-80. 
(49)  Villemin D, Cherqaoui D, Mesbah A. Predicting carcinogenicity of polycyclic aromatic 
hydrocarbons from back-propagation neural network. J Chem Inf Comput Sci 1994; 34:1288-
1293. 
(50)  Richard AM, Woo YT. A CASE-SAR analysis of polycyclic aromatic hydrocarbon 
carcinogenicity. Mutat Res 1990; 242:285-303. 
 108
  
1.6  Halogenated aliphatics 
(51)  Benigni R, Andreoli C, Conti L, Tafani P, Cotta-Ramusino M, Carere A, Crebelli R. 
Quantitave structure-activity relationship models correctly predict the toxic and 
aneuploidizing properties of six halogenated methanes in Aspergillus nidulans. Mutag 1993; 
8:301-305. 
(52)  Crebelli R, Andreoli C, Carere A, Conti L, Crochi B, Cotta-Ramusino M, Benigni R. 
Toxicology of halogenated aliphatic hydrocarbons: structural and molecular determinants for 
the disturbance of chromosome segregation induction of lipid peroxidation. Chem Biol 
Interact 1995; 98:113-129. 
(53)  Basak SC, Balasubramanian K, Gute BD, Mills D, Gorcynska A, Roszak S. Prediction of 
cellular toxicity of halocarbons from computed chemodescriptors: a hierarchical QSAR 
approach. J Chem Inf Comput Sci 2003. 
  
1.7  Direct acting compounds 
1.7.1  Platinum amines 
(54)  Hansch C, Venger BH, Panthananickal A. Mutagenicity of substituted (o-
phenylendiamine)platinum dichloride in the Ames tes. A quantitative structure-activity 
analysis. J Med Chem 1980; 23:459. 
  
1.7.2  Furanones 
(55)  LaLonde RT, Leo H, Perakyla H, Dence CW, Farrell RP. Associations of the bacterial 
mutagenicity of halogenated 2(5H)-furanones with their MNDO-PM3 computed properties 
and mode of reactivity with sodium borohydride. Chem Res Toxicol 1992; 5:392-400. 
(56)  Tuppurainen K. Frontier orbital energies, hydrophobicity and steric factors as physical QSAR 
descriptors of molecular mutagenicity. A review with a case study: MX compounds. 
Chemosphere 1999; 38:3015-3030. 
  
1.7.3  Epoxides  
(57)  Hooberman BH, Chakraborty PK, Sinsheimer JE. Quantitative structure-activity relationships 
for the mutagenicity of propylene oxides with Salmonella. Mutat Res 1993; 299:85-93. 
(58)  Sugiura K, Goto M. Mutagenicity of styrene oxide derivatives on bacterial test systems: 
relationship between mutagenic potency and chemical reactivity. Chem Biol Interact 1981; 
35:71-91. 
 109
(59)  Tamura N, Takahashi K, Shirai N, Kawazoe Y. Studies on chemical carcinogens 
XXI.Quantitative structure-mutagenicity relationships among substituted styrene oxides. 
Chem Pharm Bull 1982; 30:1393-1400. 
  
1.8  Aliphatic aldehydes 
(60)  Benigni R, Passerini L, Rodomonte A. Structure-activity relationships for the mutagenicity 
and carcinogenicity of simple and α−β unsaturated aldehydes. Environ Mol Mutagen 2003; 
42:136-143. 
(61)  Benigni R, Conti L, Crebelli R, Rodomonte A, Vari' MR. Simple and α−β -unsaturated 
aldehydes: correct prediction of genotoxic activity through Structure-Activity Relationship 
models. Environ Mol Mutagen 2005; 46:268-280. 
  
2.  (Q)SARs for noncongeneric sets of chemicals 
 
2.1  Mutagenicity 
(62)  Ashby J. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. 
Environ Mutagen 1985; 7:919-921. 
(63)  Kazius J, McGuire R, Bursi R. Derivation and Validation of Toxicophores for Mutagenicity 
Prediction. J Med Chem 2005; 48:312-320. 
(64)  Kazius J, Nijssen S, Kok J, Back T, Ijzerman AP. Substructure mining using elaborate 
chemical representation. J Chem Inf Model 2006; in press. 
(65)  Bailey AB, Chanderbhan N, Collazo-Braier N, Cheeseman MA, Twaroski ML. The use of 
structure-activity relationship analysis in the food contact notification program. Regulat 
Pharmacol Toxicol 2005; 42:225-235. 
(66)  Helma C, Cramer T, Kramer S, De Raedt L. Data mining and machine learning techniques for 
the identification of mutagenicity inducing substructures and structure activity relationships of 
noncongeneric compounds. J Chem Inf Comp Sci 2004; 44:1402-1411. 
(67)  Lewis DFV, Ioannides C, Parke DV. A quantitative structure-activity relationship (QSAR) 
study of mutagenicity in several series of organic chemicals likely to be activated by 
Cytochrome P450 enzymes. Teratog Carcinog Mutagen 2003; 1:187-193. 
(68)  Basak SC, Mills D, Gute BD, Hawkins DM. Predicting mutagenicity of congeneric and 
diverse sets of chemicals using computed molecular descriptors: a hierarchical approach. In: 
Benigni R, editor. Quantitative Structure-Activity Relationship (QSAR) models of chemical 
mutagens and carcinogens. Boca Raton: CRC Press, 2003: 207-234. 
(69)  Brinn M, Walsh P, Payne M, Bott B. Neural network classification of mutagens using 
structural fragment data. SAR QSAR Environ Res 1992; 1:169-211. 
 110
(70)  Contrera JF, Matthews EJ, Kruhlak NL, Benz RD. In silico screening of chemicals for 
bacterial mutagenicity using electropological E-state indices and MDL QSAR software. 
Regulat Pharmacol Toxicol 2005; 43:313-323. 
(71)  Maran U, Sild S. QSAR modeling of genotoxicity on non-congeneric sets of organic 
compounds. Artific Intell Rev 2003; 20:13-38. 
(72)  Mekenyan O, Dimitrov S, Serafimova R, Thompson ED, Kotov S, Dimitrova N, Walker JD. 
Identification of the structural requirements for mutagenicity by incorporating molecular 
flexibility and metabolic activation of chemicals I: TA100 model. Chem Res Toxicol 2004; 
17:753-766. 
(73)  Votano JR, Parham M, Hall LH, Kier LB, Oloff S, Tropsha A, Xie Q, Tong W. Three new 
consensus QSAR models for the prediction of Ames genotoxicity. Mutag 2005; 19:365-377. 
  
2.2  Carcinogenicity 
(74)  Helma C. Lazy Structure-Activity Relationhsips (lazar) for the prediction of Rodent 
Carcinogenicity and Salmonella mutagenicity. Molecular Diversity, 2006; in press. 
http://www.predictive-toxicology.org/lazar/index.html  
(75)  Matthews EJ, Contrera JF. A new highly specific method for predicting the carcinogenic 
potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regulat 
Pharmacol Toxicol 1998; 28:242-264. 
(76)  Contrera JF, Matthews EJ, Benz RD. Predicting the carcinogenic potential of pharmaceuticals 
in rodents using molecular structural similarity and E-state indices. Regulat Toxicol 
Pharmacol 2003; 38:243-259. 
(77)  King RD, Srinivasan A. Prediction of Rodent Carcinogenicity Biossays from Molecular 
Structure Using Inductive Logic programming. Environ Health Perspect 1996; 
104(suppl.5):1031-1040. 
(78)  Lewis DFV, Ioannides C, Parke DV. Validation of a novel molecular orbital approach 
COMPACT for the prospective safety evalution of chemicals, by comparison with rodent 
carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP. Mutat Res 
1993; 291:61-77. 
 
 
 111
              
 8 Appendix 2   Scoring results for selected models 
              
    Unambiguous algorithm Applicability Statistics Mechanism Others 
  Model A1 A2.1 A2.2 A2.3 A3 B C1 C2 C3 D E1 E2 
1.1. Aromatic Amines 115
1.1.1                           
  4 1 1 1 1 1 2 1 1 (ref. 5) 2 1 95   
  6 1 1 1 2 4 3 1 1 2 2 73   
  7 1 1 1 2 4 3 1 1 2 2 127   
  8 2 1 1 2 3 3 1 1 2 2 95   
  9 1 1 1 2 4 3 1 1 2 2 95   
  10 1 1 1 2 2 3 1 1 2 2 95   
  11 2 1 1 2 2 3 1 1 1 2 334   
  12 2 1 1 2 4 3 1 1 2 2 95   
  13 1 1 1 2 2 3 1 1 1 (ref. 14) 2 95   
  21 1 1 1 1 2 2 1 2 2 1 80   
1.1.2                           
  23 1 1 1 1 1 2 1 2 2 1 58   
  24 1 1 1 1 1 2 1 1 (ref. 5) 2 1 82   
  25 2 1 1 2 4 3 1 1 2 2 45   
  26 2 1 1 2 2 3 1 1 2 2 104   
1.2.1 Nitroarenes 42
  28 2 1 1 2 3 3 1 1 2 2 114   
  32 1 1 1 1 1 3 1 2 2 1 197   
  33 1 1 1 1 1 2 1 2 2 1 132   
  34 1 1 1 1 3 3 1 1 2 2 188+42   
  35 1 1 1 2 1 2 1 2 2 1 23   
  36 1 1 1 2 2 2 1 2 2 1 46   
1.2.2 N-nitroso 0
  42 1 1 1 2 1 2 1 2 2 2 61   
1.5. PAH 6
  47 1 1 1 1 1 2 1 2 2 1 239   
  48 2 1 1 2 4 3 1 1 2 2 78   
  49 2 1 1 2 4 3 1 1 2 2 94   
  50 1 1 1 1 3 2 1 1 1 1 102   
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1.6. Halogenated Aliphatics 113
  52 1 1 1 1 2 3 1 2 1 1 55   
  53 2 1 1 2 4 3 1 1 2 2 55   
1.7.2 Furanones 3
  56 1 1 1 1 1 2 1 2 2 1 24   
1.8. Aliphatic Haldehydes 33
  60 1 1 1 1 1 3 1 1 1 (ref. 61) 1 29   
                            
2.1. Non congeneric mutagens   
  62 N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 1 N.A.   
  63 1 1 1 1 1 3 1 2 1 1 4337   
  64 1 1 1 1 2 3 1 1 2 1 4069   
  65 N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 1 N.A.   
  68 1 2 2 2 4 3 1 1 2 2 508   
  69 2 2 2 2 4 3 1 1 2 2 607   
  70 2 2 2 2 3 2 1 1 2 2 3338   
  71 1 1 1 2 3 3 1 1 2 2 177+212   
  72 1 2 2 2 3 1 1 1 2 2 336   
  73 2 2 2 2 3 2 1 1 2 2 3363   
2.2. Non congeneric carcinogens   
  74 1 1 1 2 3 1 1 1 1 2 1447   
  76 2 2 2 2 3 2 1 1 1 2 1275   
  77 1 1 1 1 3 2 1 1 2 2 330   
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9 Appendix 3 Regression-based models for mutagenicity and carcinogenicity 
 
Ref. 4  (Debnath et al., 1992)   
                                                                                                          
Mutagenicity of aromatic amines in  S. typhimurium TA98 and TA100 strains, with S9 metabolic 
activation.  
 
 
logTA98 = 1.08 (± 0.26) logP + 1.28 (±0.64) HOMO - 0.73 (±0.41) LUMO  + 1.46 (±0.56) IL + 
7.20 (±5.4) 
     n=88        r=0.898        s=0.860                  
 
    
logTA100 = 0.92 (±0.23) logP + 1.17 (±0.83) HOMO - 1.18 (±0.44) LUMO + 7.35 (±6.9) 
         n=67     r=0.877      s=0.708         
 
logTA98 and logTA100:  mutagenic potency as  log(revertants/nmol) 
logP: logarithm of the octanol / water partition coefficient 
HOMO: energy of the Highest Occupied Molecular Orbital  
LUMO: energy of the Lowest Unoccupied Molecular Orbital  
IL : indicator variable, 1 for compounds with three or more fused rings 
 
 
Ref 10  (Gramatica et al., 2003) 
 
Mutagenicity of aromatic amines in  S. typhimurium TA98 and TA100 strains, with S9 metabolic 
activation.  
 
 
logTA98 = - 3.98 + 2.40 MWC07 + 0.56 MATS7m + 2.44 Mor27u + 1.12 Mor15m  
                  n = 60; r2 = 80.3; Q2LOO = 76.6; Q2LMO = 75.9; Q2ext = 68.9; Kxx = 27.9;  
                  s = 0.827; F(55) = 55.87; SDEC = 0.791; SDEP = 0.861; SDEPext = 0.991 
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logTA100 = - 3.99 – 0.61 nHA + 9.55 ATS5p + 0.65 L2v 
                 n = 46;  r2 = 81.2; Q2LOO = 78.0; Q2LMO = 77.4; Q2ext = 67.1; Kxx = 17.1;  
                  s = 0.579; F(42) = 60.40; SDEC = 0.553; SDEP = 0.598; SDEPext = 0.731 
 
The definitions of the parameters are in the original references quoted in Ref. 10.   
 
Ref 23  (Benigni et al., 2000) 
 
Carcinogenic potency of aromatic amines in rodents 
 
 
BRM = 0.88(±0.27) logP*I(monoNH2) + 0.29(±0.20) logP*I(diNH2)  + 1.38(±0.76) HOMO - 
1.28(±0.54) LUMO - 1.06(±0.34) ΕMR2,6 - 1.10(±0.80) MR3 - 0.20(±0.16) ES(R) + 0.75(±0.75) 
I(diNH2) + 11.16(±6.68) 
                                         n = 37    r = 0.907    r2 = 0.823    s = 0.381    F = 16.3    P < 0.001                                  
 
 
BRR = 0.35(±∀0.18) logP + 1.93(±∀0.48) I(Bi) + 1.15(±0.60) I(F) -1.06(±0.53) I(BiBr) + 
2.75(±0.64) I(RNNO) - 0.48(±0.30)                                                        
                                          n = 41    r = 0.933    r2 = 0.871    s = 0.398    F = 47.4    P < 0.001    
 
BRM = log (MW/TD50)mouse  
BRR = log (MW/TD50)rat. 
TD50: daily dose required to halve the probability for an experimental animal of remaining 
tumorless to the end of its standard life span. 
ΕMR2,6,: sum of Molar Refractivity of substituents in the ortho-positions of the aniline ring;  
MR3, Molar Refractivity of substituents in the meta-position of the aniline ring;  
Es(R), Charton’s substituent constant for substituents at the functional amino group;  
I(monoNH2) = 1 for compounds with only one amino group;  
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I(diNH2) = 1 for compounds with more than one amino group;  
I(Bi) = 1 for biphenyls;  
I(I(BiBr) = 1 for biphenyls with a bridge between the phenyl rings;  
I(RNNO) = 1 for compounds with the group N(Me)NO;  
I(F) = 1 for aminofluorenes.  
            
 
 Ref 24  (Franke et al., 2001) 
 
Carcinogenicity of aromatic amines in rodents (discriminant analysis) 
 
w = -2.86 L(R ) + 2.65 B5( R) –1.16 HOMO + 1.76 LUMO + 0.40 MR3 + 0.58 MR5 + 0.54 MR6 
–1.55 I(An) + 0.74 I(NO2) –0.55 I(BiBr) 
 
w(mean,Class1) = -1.56 N1 = 13 
w(mean,Class2) = 0.38 N2 = 53 
N1 = number of non-carcinogens (Class 1);  
N2 = number of carcinogens (Class 2);  
L(R ): Sterimol length; 
B5( R) Sterimol maximal width; 
MR3, MR5, MR6: MR contributions of substituents in position 3, 5, and 6 to the amino group;  
I(An): 1 for anilines; 
I(NO2): 1 for the presence of a NO2 group; 
I(BiBr): 1 for biphenyls with a bridge between the phenyl rings;  
 
 
Ref 32  (Debnath et al., 1991) 
 
Mutagenicity of aromatic and heteroaromatic nitro compounds in S. typhimurium strain TA98 
    
log TA98 = 0.65(±0.16)logP –2.90(±0.59)log (β 10logP +1) –1.38(±0.25)LUMO   
+1.88(±0.39)I1 –2.89(±0.81)Ia –4.15(±0.58)        
                                     n=188, r=0.900, s=0.886, logP0=4.93, logβ=5.48,F1,181=48.6 
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I1  :  1 for compounds with 3 or more fused rings;  
Ia  : 1 for 5 substances of the set  that are much less active than expected.                                                                
 
 
Ref 33  (Debnath et al., 1992b) 
    
Mutagenicity of nitroarenes in S.  typhimurium TA100, without metabolic activation 
 
log TA100 =1.20(±0.15)logP –3.40(±0.74)log(β 10logP  +1) –2.05(±0.32)LUMO – 
                                     3.50(±0.82) Ia  +1.86(±0.74)Iind –6.39(±0.73) 
                       n=117, r=0.886, s=0.835, logP0 =5.44(±0.24), log β = -5.7, F1,110=24.7      
 
Ia :  1 for compounds where acenthrylene ring is present;   
Iind : 1 for the 1- and 2-methylindazole derivatives. 
 
 
Ref 35  (Debnath and Hansch, 1992) 
 
Mutagenicity of polycyclic aromatic nitro compounds in the SOS chromotest  in Escherichia coli 
PQ37. 
log SOSIP = 1.07 (±0.36) logP – 1.57 (±0.57) LUMO  – 6.41(±1.8)                      
                                                     n=15, r=0.922, s=0.534, F1,12=36.21                              
  
SOSIP: SOS induction factor/ nmole. 
   
 
Ref 36  (Debnath et al., 1993) 
 
Genotoxicity of nitrofurans in the SOS chromotest  in Escherichia coli PQ37. 
 
log SOSIP= -33.1(±11.9) qc2  +1.00(±0.26)logP –1.50(±0.49) Isat –1.19(±0.49)MR –                                             
                                      0.76(±0.49)I 5,6 –3.76(±1.56) 
                                                                 n=40, r=0.900, s=0.475, F1,34=9.76  
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qc2 : partial atomic charge on the carbon attached to the nitro group;  
Isat : 1 for saturated ring compounds;  
I 5,6  : 1 for compounds with substituents at the 5- or 6- position of 2-nitronaphthofurans and 
pyrenofurans.  
 
 
Ref 47  (Zhang et al., 1992) 
 
 Skin carcinogenicity of polycyclic aromatic hydrocarbons 
    
 log Iball= 0.55(±0.09)logP –1.17(±0.14) log (β 10logP +1)   +0.39(±0.11)LK + 
                     0.47(±0.26)HOMO +1.93(±2.4)  
                           n=161, r=0.845, s=0.350, logP0= 6.67(±0.217), logβ =-6.81, F1,155=12.8 
 
Iball index  = (Tumor incidence) (100%) / mean latent period in days, 
where Tumor incidence = number of animal with tumors / number of animals alive when the first 
tumor appears. 
 LK: 1 for compounds with a substituent attached to a L or K region. 
 
 
Ref 52  (Crebelli et al., 1995) 
 
Induction of aneuploidy by halogenated aliphatics in A. nidulans 
 
Log (1/LEC) = 0.83 + 0.07 MR – 4.91 LUMO – 3.41 DIFF 
                         N = 24; Ftot = 69.07  
 
LEC:  Lowest Effective Concentration; 
DIFF: LUMO – HOMO. 
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Ref 56  (Tuppurainen, 1999)  
  
Mutagenicity of  halogenated furanones (lactones) in S. typhimurium TA100 
 
    lnTA100= -12.7(±1.1)LUMO –12.0(±1.3)                                 
                                   n=24, r=0.930, s=1.33,  F=141.0 
 
 
Ref 60  (Benigni et al., 2003) 
 
Mutagenicity of α−β unsaturated aldehydes in S. typhimurium TA100 
 
logTA100 =  – 12.61592  –  4.58430 LUMO  – 3.66205 MR  + 72.46140 C-carb + 2.55239 logP + 
13.09442 C-β 
                 n = 17; r2 = 0.84;  q2 = 0.40 
 
C-carb= partial charge on the carbonilic carbon; 
C-β = partial charge on the β carbon. 
 
Mutagenicity of α−β unsaturated aldehydes in S. typhimurium TA100 (discriminant analysis) 
 
Negatives =  -  47.13331  +  38.24641 MR   -  31.77763 logP  +  30.46.799 LUMO 
Positives =    -  20.52153  +  25.41469 MR   -  21.45102 logP  +  19.77513  LUMO  
 
   n = 20;  100% correct reclassification;  3/20 errors in cross-validation.  
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Abstract 
This evaluation of the non-commercial (Q)SARs for mutagenicity and 
carcinogenicity consisted of a preliminary survey (Phase I), and then of a 
more detailed analysis of short listed models (Phase II). In Phase I, the 
models were collected from the literature, and then assessed according to the 
OECD principles –based on the information provided by the authors-. Phase I 
provided the support for short listing a number of promising models, that were 
analyzed more in depth in Phase II. In Phase II, the information provided by 
the authors was completed and complemented with a series of analyses 
aimed at generating an overall profile of each of the short listed models.  
The models can be divided into two families based on their target: a) 
congeneric;  and b) non-congeneric sets of chemicals.  
The QSARs for congeneric chemicals include most of the chemical classes 
top ranking in the EU High Production Volume list, with the notable exception 
of the halogenated aliphatics. They almost exclusively aim at modeling 
Salmonella mutagenicity and rodent carcinogenicity, which are crucial 
toxicological endpoints in the regulatory context. The lack of models for in vivo 
genotoxicity should be remarked. Overall the short listed models can be 
interpreted mechanistically, and agree with, and/or support the available 
scientific knowledge, and most of the models have good statistics. Based on 
external prediction tests, the QSARs for the potency of congeneric chemicals 
are 30 to 70 % correct, whereas the models for discriminating between active 
and inactive chemicals have considerably higher accuracy (63 to 100 %), thus 
indicating that predicting intervals is more reliable than predicting individual 
data points. The internal validation procedures (e.g., cross-validation, etc...) 
did not seem to be a reliable measure of external predictivity.   
Among the non-local, or global approaches for non-congeneric data sets, four 
models based on the use of Structural Alerts (SA) were short listed and 
investigated in more depth. The four sets did not differ to a large extent in 
their performance. In the “general” databases of chemicals the SAs appear to 
agree around 65% with rodent carcinogenicity data,  and 75% with Salmonella 
mutagenicity data. The SAs based models do not seem to work equally 
efficiently in the discrimination between active and inactive chemicals within 
individual chemical classes. Thus, their main role is that of preliminary, or 
large-scale screenings. A priority for future research on the SAs is their 
expansion to include alerts for nongenotoxic carcinogens.  
   A general indication of this study, valid for both congeneric and 
noncongeneric models, is that there is uncertainty associated with (Q)SARs; 
the level of uncertainty has to be considered when using (Q)SAR in a 
regulatory context. However, (Q)SARs are not meant to be black-box 
machines for predictions, but have a much larger scope including organization 
 and rationalization of data, contribution to highlight mechanisms of action, 
complementation of other data from different sources (e.g., experiments). 
Using only non-testing methods, the larger the evidence from QSARs (several 
different models, if available) and other approaches (e.g. chemical categories, 
read across) the higher the confidence in the prediction. 
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